EP3247445B1 - Balloon catheter suturing systems and devices having pledgets - Google Patents
Balloon catheter suturing systems and devices having pledgets Download PDFInfo
- Publication number
- EP3247445B1 EP3247445B1 EP16708482.1A EP16708482A EP3247445B1 EP 3247445 B1 EP3247445 B1 EP 3247445B1 EP 16708482 A EP16708482 A EP 16708482A EP 3247445 B1 EP3247445 B1 EP 3247445B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- balloon
- pledget
- cases
- balloon catheter
- catheter suturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000835 fiber Substances 0.000 claims description 60
- 229920001187 thermosetting polymer Polymers 0.000 claims description 37
- -1 polydimethylsiloxane Polymers 0.000 claims description 23
- 239000000017 hydrogel Substances 0.000 claims description 16
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 10
- 229920001296 polysiloxane Polymers 0.000 claims description 6
- 239000000463 material Substances 0.000 description 48
- 238000000034 method Methods 0.000 description 46
- 238000012800 visualization Methods 0.000 description 19
- 229920000642 polymer Polymers 0.000 description 17
- 239000002121 nanofiber Substances 0.000 description 16
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 210000003709 heart valve Anatomy 0.000 description 12
- 210000003484 anatomy Anatomy 0.000 description 10
- 229920001223 polyethylene glycol Polymers 0.000 description 10
- 230000000007 visual effect Effects 0.000 description 10
- 238000001523 electrospinning Methods 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 238000009987 spinning Methods 0.000 description 7
- 210000000591 tricuspid valve Anatomy 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000003373 anti-fouling effect Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000012780 transparent material Substances 0.000 description 3
- 208000032750 Device leakage Diseases 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 239000004813 Perfluoroalkoxy alkane Substances 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 230000002965 anti-thrombogenic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 229920011301 perfluoro alkoxyl alkane Polymers 0.000 description 2
- 229920006219 poly(vinylidene fluoride-co-hexafluoropropene) Polymers 0.000 description 2
- 229920002187 poly[N-2-(hydroxypropyl) methacrylamide] polymer Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000012815 thermoplastic material Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 1
- 229920002430 Fibre-reinforced plastic Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920000571 Nylon 11 Polymers 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 201000001943 Tricuspid Valve Insufficiency Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011151 fibre-reinforced plastic Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- PQIOSYKVBBWRRI-UHFFFAOYSA-N methylphosphonyl difluoride Chemical group CP(F)(F)=O PQIOSYKVBBWRRI-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00064—Constructional details of the endoscope body
- A61B1/00071—Insertion part of the endoscope body
- A61B1/0008—Insertion part of the endoscope body characterised by distal tip features
- A61B1/00082—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00064—Constructional details of the endoscope body
- A61B1/00071—Insertion part of the endoscope body
- A61B1/0008—Insertion part of the endoscope body characterised by distal tip features
- A61B1/00087—Tools
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00147—Holding or positioning arrangements
- A61B1/00148—Holding or positioning arrangements using anchoring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/012—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor
- A61B1/018—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor for receiving instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/05—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances characterised by the image sensor, e.g. camera, being in the distal end portion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/06—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with illuminating arrangements
- A61B1/0661—Endoscope light sources
- A61B1/0676—Endoscope light sources at distal tip of an endoscope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/313—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for introducing through surgical openings, e.g. laparoscopes
- A61B1/3137—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for introducing through surgical openings, e.g. laparoscopes for examination of the interior of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0644—Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/122—Clamps or clips, e.g. for the umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
- A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/122—Clamps or clips, e.g. for the umbilical cord
- A61B17/1227—Spring clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/128—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for applying or removing clamps or clips
- A61B17/1285—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for applying or removing clamps or clips for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
- A61B2017/00783—Valvuloplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00902—Material properties transparent or translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00902—Material properties transparent or translucent
- A61B2017/00907—Material properties transparent or translucent for light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0406—Pledgets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0409—Instruments for applying suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
- A61B2017/0472—Multiple-needled, e.g. double-needled, instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
- A61B2017/048—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery for reducing heart wall tension, e.g. sutures with a pad on each extremity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06004—Means for attaching suture to needle
- A61B2017/06042—Means for attaching suture to needle located close to needle tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B2017/0649—Coils or spirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/306—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/309—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using white LEDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/361—Image-producing devices, e.g. surgical cameras
- A61B2090/3612—Image-producing devices, e.g. surgical cameras with images taken automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1075—Balloon catheters with special features or adapted for special applications having a balloon composed of several layers, e.g. by coating or embedding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1088—Balloon catheters with special features or adapted for special applications having special surface characteristics depending on material properties or added substances, e.g. for reducing friction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
Definitions
- balloon catheter suturing systems, methods, and devices can include pledgets.
- Heart function can be significantly impaired when a heart valve is not performing properly.
- Potential causes for heart valve malfunction include dilation of an annulus around the valve, ventricular dilation, and a prolapsed or misshapen valve leaflet.
- Heart valve When the heart valve is unable to close properly, blood within a heart chamber can leak backwards, through the valve, which is commonly referred to as regurgitation.
- Valve regurgitation may be treated by replacing or repairing a diseased valve.
- the most common method of correcting tricuspid valve regurgitation is to reduce the annulus by bringing the anterior and septal leaflets closer together using sutures.
- precut sheet pieces of polytetra-fluorethylene (PTFE), also known as pledgets are used with the sutures to cushion the load of the suture against host tissue.
- PTFE polytetra-fluorethylene
- EP2508222A1 discloses an apparatus for delivering a therapeutic and/or diagnostic agent to tissue within a bodily cavity.
- the apparatus may include a catheter assembly including a catheter and a delivery balloon having an expandable material disposed thereon, wherein the expandable material may be an absorbent at least partially charged with a therapeutic and/or diagnostic agent.
- Balloon catheter suturing systems provided herein can be used to suture one or more anatomical locations using less invasive techniques while providing visualization of the anatomical location.
- balloon catheter suturing systems provided herein include an elongate shaft defining a lumen and having a distal end portion and a proximal end portion, a balloon attached to the distal end portion, and at least a first pledget secured to the balloon by a portion of the balloon catheter suturing system adjacent the balloon.
- the balloon catheter suturing system includes at least one fastener adapted to fasten the first pledget to an anatomic structure when the balloon catheter suturing system is positioned within a patient.
- the balloon is a weeping balloon.
- the first pledget is part of the transparent wall. In some cases, the first pledget is held by an internal pledget support structure within the transparent wall of the balloon. In some cases, the first pledget is held by a first pledget support structure outside the transparent wall of the balloon distal to the balloon.
- balloon catheter suturing systems further comprise a second pledget held by a second pledget support structure proximal to the first pledget, wherein at least one fastener is adapted to fasten the first and second pledgets together on opposite sides of the anatomic structure.
- the second pledget is positioned within the transparent wall of the balloon. In some cases, the second pledget is positioned outside of the transparent wall.
- the first pledget is defined by weakened sections defining one or more tear lines around the first pledget in the transparent wall. In some cases, the first pledget is adapted to delaminate from a portion of the transparent wall. In some cases, the transparent wall comprises at least a first layer comprising a thermoset polymer and a plurality of polymeric fibers at least partially embedded in the thermoset polymer. In some cases, the transparent wall comprises at least a second layer disposed on the first layer, wherein the second layer comprises a hydrogel.
- the balloon catheter suturing system can include a transparent wall including at least a first layer comprising a thermoset polymer and a plurality of polymeric fibers at least partially embedded in the thermoset polymer.
- the transparent wall can include at least a second layer disposed on the first layer.
- the second layer can include a hydrogel.
- the polymeric fibers can be electrospun fibers randomly oriented within the thermoset polymer.
- the thermoset polymer comprise a silicone, such as polydimethylsiloxane (PDMS).
- the balloon catheter suturing system can have any suitable balloon shape.
- the balloon can be configured such that sutures are passed through the balloon.
- the balloon can define a working channel there through.
- the balloon is a weeping balloon.
- a method for repairing a heart valve in a patent can include advancing a balloon end of a balloon catheter into an atrium of a heart, imaging a portion of a heart valve, passing a suture through at least one detachable section to suture a portion of the heart valve to the at least one detachable section, and separating the at least one detachable section from the balloon catheter.
- the balloon catheter can include one or more elongate shafts in fluid communication with a balloon having a transparent wall.
- the transparent wall can define the at least one detachable section.
- the transparent wall can define multiple detachable sections.
- a portion of a heart valve is imaged through the transparent wall using an imaging element disposed within the balloon through the one or more elongate shafts.
- the at least one detachable section is separated from the balloon catheter by deflating the balloon and removing the balloon catheter from the heart.
- the transparent wall defines the one or more detachable sections with weakened tear lines that tear when the balloon is removed from the heart.
- a plurality of sutures are attached to multiple parts of a heart valve through a plurality of detachable sections prior to separating the plurality of detachable sections.
- the heart valve is a tricuspid valve.
- a valve annulus is sutured to the at least one detachable section.
- Balloon catheter suture devices, systems and methods provided herein include features that improve minimally invasive surgical techniques used during a heart valve repair procedure such as, but not limited to, procedures that suture one or more heart valve leaflets.
- Exemplary procedures include those that bicuspidizes a tricuspid valve, edge to edge stitching techniques (or Alfieri stitches), mitral valve stitches, closures of paravalvular leaks, percutaneous paravalvular leak closure, and/or percutaneous closure of prevalvular leaks.
- suture is used herein to refer to any fastening of anatomical structures, which can be made with any suitable fastener including suturing thread, clips, staples, hooks, tacks, clamps, etc.
- Balloon catheter suture devices, systems, and methods provided herein include pledgets retained at an external end of the balloon catheter suturing device.
- the pledgets are adapted to be sutured to an anatomical location, separate from the balloon catheter, and remain with a resulting suture.
- the term "pledget" will refer to a piece of material that is intended be sutured to an anatomical location.
- the wall of the balloon can include portions arranged to be sutured to an anatomical location through the transparent wall and to separate from the remainder of the balloon catheter to become a pledget.
- balloon catheter suturing devices, systems, and methods provided herein can include one or more pledgets held by the balloon catheter suturing devices and systems provided herein and positioned inside and/or outside the balloon such that the pledget(s) can be secured to an anatomical location using one or more fasteners.
- balloon catheter suturing devices, systems, and methods provided herein can include cooperating pledgets that are arranged to clamp around an anatomical structure have one or more fasteners passed there through.
- Balloon catheter suture devices, systems, and methods provided herein can allow for direct visualization of a target location, which can provide anatomy and pathology identification as well as device placement visual feedback to the physician user during a minimally invasive method.
- Balloon catheter suturing devices, systems, and methods provided herein can include an elongate, compliant balloon having a transparent wall.
- the transparent wall can include portions arranged to be sutured to an anatomical location through the transparent wall and to separate from the remainder of the balloon catheter.
- the balloon can include pores to allow for the balloon to "weep" to provide a visually clear area surrounding the balloon.
- the balloon wall e.g., a transparent balloon wall
- the balloon can have a structure that limits the propagation of tears.
- the balloon all can include polymeric fibers within a matrix of a second material.
- FIG. 1A shows an exemplary balloon catheter suturing system 100 within a human anatomy.
- Balloon catheter visualization system 100 can be inserted into a right atrium of a heart through a brachial vein or a jugular vein.
- balloon catheter suturing system 100 includes an elongate shaft or tubular body 112 having a proximal end portion 114 with a proximal end 116 and a distal end portion 118 with a distal end 120.
- Proximal end portion 114 can couple to a manifold 122.
- Distal end portion 118 can include an integrated camera (not shown), a fastening tool 124 with a fastener and at least one balloon 108 (also described as balloon member).
- Integrated camera and fastening tool 124 can be disposed within balloon 108.
- balloon 108 can form a distal tip of balloon catheter suturing system 100.
- the fastening tool 124 can pass a fastener through the balloon to suture an anatomical location outside the balloon.
- the balloon can be filled with an inflation medium, such as saline solution, that can be safely delivered to the patient, thus leakage from resulting holes in the balloon caused by the passing of the fastener through the balloon can be tolerated.
- Balloon catheter suturing system 100 can include a pledget 126 located distal to fastening tool 124 such that a fastener delivered through the balloon is also delivered through pledget 126 to suture pledget 126 to an anatomical location.
- Pledget 126 can, in some cases, be a part of the balloon wall of balloon 108 adapted to tear away from the balloon wall.
- pledget 126 is laminated to an outside surface of the balloon wall.
- a balloon wall can include weakened sections or weakened tear lines such that pledget 126 tears away from balloon 108 to leave a pledget sized hole.
- pledget 126 can be held within balloon 108. In some cases, pledget 126 can be held adjacent the exterior of balloon 108.
- balloon catheter suturing system 100 includes at least one tubular body 112 defining a lumen (not shown).
- balloon catheter suturing system 100 can include multiple tubular bodies, in which each tubular body defines at least one lumen.
- Each tubular body 112 can optionally include multiple lumens, for example, coaxial or non-coaxial lumens.
- Balloon catheter suturing system 100 can have one or more lumens that extend partially or fully thorough one or more tubular bodies 112.
- One or more lumens can be used as a conduit adapted to receive components, e.g., integrated camera or fastener tools, and/or inflation media, e.g., saline.
- one or more lumens can be adapted to jet inflation media, e.g., saline, into distal end portion 118 of balloon catheter suturing system 100.
- Manifold 122 generally connects an external fluid supply to one or more lumens of balloon catheter suturing system 100.
- Manifold 122 can include one or more ports 128 to facilitate a fluid connection to another medical device or a fluid source.
- port 128 can supply saline solution into one or more lumens of tubular body 112.
- Manifold 122 may be coupled to tubular body 112 directly or indirectly.
- a flexible tubing sometimes referred to as a strain relief tubing, is coupled between manifold 122 and the tubular body 112 at the proximal end 116 to provide a longitudinal tapered transition between manifold 122 and tubular body 112.
- Flexible tubing can help to increase kink resistance of tubular body 112 at proximal end portion 114.
- FIG. 1B depicts an distal end of exemplary balloon catheter system 100 having a balloon 108 having tear lines 196, or weakened sections, in the balloon wall 164 that define pledgets 126. Pledgets 126 are adapted to be sutured to anatomical locations and separated from balloon 108.
- balloon catheter suturing system 100 that includes an elongate, tubular body 112 with a distal end portion 154.
- a distal end 156 of distal end portion 154 can be either directly or indirectly coupled to a balloon 108.
- tubular body 112 can be coupled to balloon 108 indirectly by using an intermediate catheter shaft 157.
- intermediate catheter shaft 157 couples to a proximal end 162 of balloon 108 and a catheter interface portion 158 of tubular body 112.
- balloon 108 is disposed proximate to distal end 156 of tubular body 112.
- Balloon 108 can include the proximal end 162, a distal end 163 and a wall 164 that extends from an interior surface 165 to an exterior surface 166.
- balloon 108 forms a distal tip 170 of balloon catheter suturing system 100.
- balloon 108 can be filled with an inflation media in an interior cavity 168 defined between proximal and distal ends 162, 163.
- balloon 108 can include a weeping balloon structure, i.e., a balloon structure that defines one or more perforations 172 extending through wall 164.
- distal end of tubular body can include a plurality of lumens 174.
- Each lumen of plurality of lumens 174 can longitudinally extend through tubular body 112 entirely or partially there through.
- Each lumen can be formed from one of various cross-sectional shapes, e.g., circle, oval, slot, square, rectangular, triangular, trapezoid, rhomboid, or irregular shape.
- the shape of the lumen may facilitate receiving other components of balloon catheter suturing system 100.
- one or more lumens 174 can be used to receive a fastening tool (not shown), a camera 176, fiber optic light cables (not shown), electrical cables (not shown), inflation media and combinations thereof.
- tubular body can define a central lumen 178 for receiving a fastening tool (not shown) for delivering a fastener (not shown), two lumens for receiving fiber optic light cables 180, one lumen for delivering inflation media 182, and one lumen for receiving camera 176.
- Pledgets 126 can be sutured to an anatomical location and separated from balloon 108 after suturing to become pledgets.
- pledgets 126 are laminated onto the wall of balloon 108 such that a resulting hole from the separation of the pledget is limited to the size of fasteners passed through the wall of balloon 108.
- pledgets 126 can be defined by weakened sections 196 of the balloon wall surrounding each pledget 126 such that detachment of each pledget 126 creates a pledget sized hole in balloon 108.
- pledgets 126 can each be secured to anatomical locations prior to separation.
- an inflation medium flow can be reduced or stopped prior to separation.
- Balloon 108 of balloon catheter suturing system 100 can be a weeping balloon.
- Weeping balloon in the context of the present disclosure, includes a balloon structure defining one or more perforations (also described as apertures or micropores, extending through a balloon wall).
- weeping balloons can transfer inflation media through the balloon wall, from interior cavity to exterior surface of balloon 108. Transferring inflation media to exterior surface can provide a benefit of displacing blood from exterior surface of balloon 108 that would otherwise blur or obstruct visual imaging through balloon 108. In other words, inflation media transferred through the one or more perforations can help keep the exterior surface visually clear.
- a weeping balloon used in a balloon catheter suturing system or device provided herein can have at least 3 punctured holes.
- weeping balloons used in balloon catheter suturing systems or devices provided herein can have between 3 and 10,000 punctured holes, between 3 and 1,000 punctured holes, between 3 and 100 punctured holes, or between 3 and 10 punctured holes.
- the number and dimensions of punctured holes in a weeping balloon used in a balloon catheter suturing system or device provided herein allows for an inflation media flow rate of between 1 and 50 ml/minute. In some cases, systems and methods provided herein control an inflation media flow rate to be between 3 ml/minute and 10 ml/minute. In some cases, a weeping balloon used in balloon catheter suturing systems and devices provided herein can have hundreds of holes that perfuse inflation media (e.g., saline) through the balloon and into the blood.
- perfuse inflation media e.g., saline
- a weeping balloon used in a balloon catheter suturing system or device provided herein can have a greater pore density in portions of the balloon wall in the center of the field of view and a lower pore density around a periphery of the field of view.
- FIG. 2 is a perspective view of another example of a balloon catheter suturing system 200.
- balloon catheter suturing system 200 includes a tubular body 202 with distal end portion 204, a pledget 206, suturing thread 212, and an integrated camera 207 disposed within a balloon 208.
- pledget 206 is held distal to balloon 208 by a pledget support 205 that extends adjacent the balloon 208 from a lumen 209 at a distal end 219 of tubular body 202 within balloon 208 while another portion of fastening element 206 extends adjacent to balloon 208.
- a portion of pledget support 205 extends around and distal to balloon 208 such that pledget 206 forms a distal tip 218 of balloon catheter suturing system 200.
- multiple pledgets 206 can be included.
- a portion of pledget 206 can extend through the balloon 208.
- a portion of pledget 206 that is disposed within interior cavity 214 can be subsequently extended through a wall of balloon 208 to an exterior environment during a medical procedure.
- Balloon catheter suturing system 200 can include a fastening tool 210 adapted to penetrate tissue, separate tissue, and/or deliver a fastener 212 through the pledget and tissue, to secure a suture to tissue and/or to attach two pieces of tissues together.
- fastener 212 is suturing thread.
- fastening tool 210 can be in the form of, for example, a needle, knife, scalpel, cutter and combinations thereof.
- staple, hook, tack, clamp, a clip, or other suturing devices can be used instead of or with suturing thread 212.
- integrated camera 207 is disposed at the distal end 219 of tubular body 202 to provide visual imaging of a patient's anatomy during the medical procedure.
- Camera 207 may be fully or partially disposed within a lumen 220 defined by tubular body 202.
- the camera can be coupled to electrical and/or optical cables (not shown) in lumen 220 that extend longitudinally through tubular body 202 towards a proximal end portion of tubular body 202.
- camera 207 is electrically connected to the external electronics with wires through lumen 220.
- a bundle of fiber optic cables, each with their own lens e.g., borescopes
- camera 207 includes externally powered but internal LEDs to emit light so that the tissue can be seen.
- systems provided herein have optical fibers and an external light source.
- a rectangular-shaped balloon 208 can be coupled to distal end 219 of tubular body 202.
- balloon 208 has a proximal end 222 and a distal end 224.
- Balloon 208 can define an interior cavity 214 that extends between proximal and distal ends 222, 224.
- Balloon 208 can be expanded by filling interior cavity 214 with an inflation media, such as saline solution.
- Balloon 208 of balloon catheter suturing system 200 can be a weeping balloon.
- Weeping balloon in the context of the present disclosure, includes a balloon structure defining one or more perforations (also described as apertures or micropores, extending through a balloon wall).
- weeping balloons can transfer inflation media through a balloon wall, from interior cavity 214 to exterior surface of balloon 208. Transferring inflation media to exterior surface can provide a benefit of displacing blood from exterior surface of balloon 208 that would otherwise blur or obstruct visual imaging through balloon 208. In other words, inflation media transferred through the one or more perforations can help keep the exterior surface visually clear.
- a weeping balloon used in a balloon catheter suturing system or device provided herein can have at least 3 punctured holes.
- weeping balloons used in balloon catheter suturing systems or devices provided herein can have between 3 and 10,000 punctured holes, between 3 and 1,000 punctured holes, between 3 and 100 punctured holes, or between 3 and 10 punctured holes.
- the number and dimensions of punctured holes in a weeping balloon used in a balloon catheter suturing system or device provided herein allows for an inflation media flow rate of between 1 and 50 ml/minute. In some cases, systems and methods provided herein control an inflation media flow rate to be between 3 ml/minute and 10 ml/minute. In some cases, a weeping balloon used in balloon catheter suturing systems and devices provided herein can have hundreds of holes that perfuse inflation media (e.g., saline) through the balloon and into the blood.
- perfuse inflation media e.g., saline
- a weeping balloon used in a balloon catheter suturing system or device provided herein can have a greater pore density in portions of the balloon wall in the center of the field of view and a lower pore density around a periphery of the field of view.
- FIGS. 3A-3J depict another exemplary balloon catheter suture delivery system 300 having a pair of pledgets 322 and 324 disposed distal to balloon 308.
- FIG. 3A depicts a distal end of system 300.
- FIGS. 3B and 3C depict a controlling handle for the system.
- FIGS. 3D-3I depict system 300 being used to suture the valve annulus 301 of a tricuspid valve.
- balloon catheter suturing system 300 includes an inner pledget 322 and an outer pledget 324.
- Inner pledget 322, as shown in FIG. 3E is held adjacent to a distal end of balloon 308 by an inner pledget support structure 332, which can extend through a channel formed in balloon 308, and outer pledget 324 is held distal to inner pledget 322 by an outer pledget support structure 334.
- balloon catheter suturing system 300 can be manipulated by a controlling handle 390 to position a distal end of system 300 as desired.
- FIG. 3D-3I the distal end can be manipulated to position tissue 301 (e.g., a valve annuals of the tricuspid valve) between inner pledget 322 and outer pledget 324 such that tissue 301 to be sutured there between.
- tissue 301 e.g., a valve annuals of the tricuspid valve
- FIG. 3D depicts balloon catheter suturing system 300 after placement, but before suturing.
- FIG. 3E depicts system 300 after suturing threads 312a and 312b have been pulled through tissue 301 and inner pledget apertures 323a and 323b.
- FIGS. 3F-3H discussed below show how this is accomplished, but do not show balloon 308 in order to more clearly show steps.
- FIGS. 3I and 3J depict pledgets 322 and 324, suturing threads 312a and 312b, and suturing attachments, needle shuttles 314a and 314b, in isolation.
- FIGS. 3D and 3F depict inner pledget 322 placed on one side of tissue 301 and outer pledget 324 positioned on an opposite of tissue 301 prior to suturing of tissue 301.
- balloon 308 is omitted from FIG. 3F for clarity.
- Suturing threads 312a and 312b can be positioned such that they extended through outer pledget apertures 325a and 325b prior to delivery of balloon catheter suturing system 300 and retained in outer pledget apertures 325a and 325b by needle shuttles 314a and 314b, which can have a larger outer diameter than the inner diameter of outer pledget apertures 325a and 325b.
- Needle shuttles 314a and 314b can include stylet receiving apertures 315a and 315b adapted to lock with opposing distal anvils 311a and 311b of stylets 310a and 310b of fastener tool 331, which are supported on stylets 310a and 310b.
- Inner pledget support structure 332, outer pledget support 334, and fastener tool 331 can be moved relative to each other by their respective shafts.
- Outer pledget support structure 334 is attached to outer pledget delivery shaft 335. As shown in FIGS. 3F , inner pledget 322 and needle shuttles 314a and 314b can be spaced to allow for tissue 301 to slide there between.
- FIG. 3G depicts the advancement of the fastener tool 331 such that distal anvils 311a and 311b of stylets 310a and 310b pass through inner pledget apertures 323a and 323b, such that opposing distal anvils 311a and 311b engage with stylet receiving apertures 315a and 315b of needle shuttles 314a and 314b.
- Opposing distal anvils 311a and 311b can have a sharp point to facilitate piercing of tissue 301.
- fastener tool 331 can be positioned in a working channel formed along or through balloon 308.
- fastener tool 331 can be positioned within balloon 308 and stylets 310a and 310b can also pierce balloon 308 prior to passing through inner pledget apertures 323a and 323b.
- balloon 308 is a weeping balloon that is resistant to tear propagation, thus balloon 308 can tolerate the formation of additional apertures formed in balloon 308 due to the passage of stylets 310a and 310b through the balloon.
- FIG. 3H depicts suturing threads 312a and 312b being pulled through tissue 301, and through inner pledget apertures 323a and 323b when the fastener tool 331 (see FIG. 3G ) retracts needle shuttles 314a and 314b proximally.
- suturing threads 312a and 312b can additionally be pulled into balloon 308.
- FIG. 3I depicts inner pledget 322 secured against tissue 301 by suturing threads 312a and 312b through holes.
- Outer pledget 324 is not shown in FIG. 3I , but is on an opposite side of tissue 301. Suturing threads 312a and 312b can be subsequently tied off or otherwise secured to complete the suture.
- inner pledget 322 can be positioned within balloon 308.
- inner pledget support structure 332 and inner pledget support shaft 333 can be positioned within balloon 308.
- balloon 308 can be torn or cut to be separated from inner pledget 322 after suturing.
- balloon 308 can be torn or cut to be separated from the pledgets 322 and 324.
- a portion of a balloon wall between pledgets 322 and 324 can rip along weakened tear lines to remain a part of the suture and an additional pledget structure.
- balloon 308 can rip to be allow inner pledget 322 to be separated from balloon catheter suturing system 300.
- balloon catheter suturing system can include a controlling handle 390 at a proximal end.
- Controlling handle 390 can include a handle 395, a trigger 391 for controlling the bend 398 of a tubular body 382 to control the placement of distal end of system 300.
- Levers 392 and 393 and knob 374 can control the advancement and/or retraction of the fastener tool 331, inner pledget support shaft 333, and outer pledget support shaft 335.
- Levers 392 and 393 and knob 374 can also control the tying of suture threads 312a and 312b.
- inner pledget support shaft 333 is integral with tubular body 382 such that levers 392 and 393 control the movement of the fastener tool 331 and the outer pledget support shaft 335 relative to the tubular body 382 and the inner pledget support shaft 333.
- knob 374 can be used to manipulate fastener tool 331 to tie suturing threads 312a and 312b together.
- a distal end of system 300 can include a plurality of channels 380 for delivery of inflation media, tools, fiber optics, cameras, etc. in tubular body 382.
- a camera 376 can be integrated into shaft tubular body 382.
- FIG. 4 depict another exemplary suture system that can be used with a balloon catheter suture delivery system provided herein.
- the suture system of FIG. 4 has stylet fasteners 412a and 412b for suturing tissue (e.g., a valve annulus of a tricuspid valve) in between an inner pledget 422 and an outer pledget 424.
- a balloon catheter suturing system provided herein can have a structure is similar to balloon catheter suturing system 300 depicted in FIGS. 3A-3I , but uses the suturing system of FIG. 4 to suture tissue to inner pledget 422 and outer pledget 424.
- Inner pledget 422 can include inner pledget apertures 423a and 423b, which hold fasteners 412a and 412b.
- Fasteners 412a and 412b can be stylet fasteners having proximal anvils 413a and 413b and distal anvils 411a and 411b.
- Proximal anvils 413a and 413b can rest on an upper surface of inner pledget 422 to prevent stylet fasteners 412a and 412b from passing entirely through apertures 423a and 423b.
- Distal anvils 411a and 411b are adapted to be received and locked into outer pledget apertures 425a and 425b in outer pledget 424.
- Stylet fasteners 412a and 412b can be advanced to pierce tissue and insert the distal anvils into the outer pledget apertures 425a and 425b by advancing an inner pledget support structure, which can cover at least a portion of proximal anvils 413a and 413b.
- Wires 414a and 414b can be releasably secured to proximal anvils 413and and 413b to hold the stylet fasteners 412a and 412b against an inner pledget support structure.
- FIG. 4 depicts inner pledget 422 and stylet fasteners 412a and 412b that can be advanced through tissue and distal anvils 411a and 411b that can be pushed into outer pledget apertures 425a and 425b. Accordingly, an inner pledget support structure and inner pledget support shaft act as a suturing tool.
- FIG. 4 shows internal locking structures 428 within external apertures 425a and 425b and how they lock distal anvils 411a and 411b of stylet fasteners 412a and 412b.
- Outer pledget 424 can include an internal plate 427.
- pledget 424 can be formed by injection molding a polymeric material around plate 427.
- Plate 427 includes two plate apertures surrounded by locking structures 428, which can clasp and lock distal anvils 411a and 411b.
- Distal anvils 411a and 411b can be conical to push locking structures out as distal anvils 411a and 411b are pressed against locking structures 428 until a bottom edge of the conical tip passes a lower edge of locking structures 428, which results in locking structures 428 snapping against a shaft of stylet fasteners 412 a and 412b.
- a bottom edge of the conical tip thus acts as a mechanical stop that locks the distal anvil from be retracted out of outer pledget apertures 425a and 425b.
- Balloons used in the balloon catheter suturing systems of FIGS. 1A-4F can use any suitable balloon shape.
- pledgets are held external to the balloons.
- balloons can include one or more working channels for one or more tools (e.g., pledget support shafts, fastening tool, etc.) to access an anatomical structure (e.g., a tricuspid valve).
- a working channel can have a balloon extend along three sides of the channel.
- a working channel can be surrounded by a donut-shaped balloon.
- balloons used in balloon catheter suturing systems 100, 200, or 300 can include tools within the balloon.
- FIGS. 5A-5F depict exemplary balloon shapes 500, 520, 540, 560, 580, and 590, which can be used in balloon catheter suturing devices and systems provided herein. Although not specifically shown in FIGS. 5A-5D , each of these balloon shapes 500, 520, 540, and 560 can include side working channels and/or through working channels.
- Balloons can be constructed from various forms, e.g., a film, sheet or tube of transparent materials. Also, balloons 500, 520, 540, 560, 580, and 590 may be formed into a variety of different shapes.
- FIG. 5A shows an example of a balloon 500 having a generally oval shape.
- FIG. 5B provides an example of a balloon 520 having a proximal spherical portion 522 and a distal spherical portion 524 with a necked portion 526 there between.
- FIG. 5C provides an example of a balloon 540 having a proximal spherical portion 542 that transitions into a distal flared portion 544.
- FIG. 5A shows an example of a balloon 500 having a generally oval shape.
- FIG. 5B provides an example of a balloon 520 having a proximal spherical portion 522 and a distal spherical portion 524 with a necked portion 526 there
- FIG. 5D shows an example of a balloon 560 having a proximal conical portion 562 coupled to a distal bulbous portion 564.
- FIG. 5E shows an example of a donut-shaped balloon 580 having a channel or thru lumen 582. Thru lumen 582 can be sized and shaped to allow blood or other medical devices to pass through.
- FIG. 5F shows an example of a half-flask shaped balloon 590 having a side working channel 592.
- balloons used in balloon catheter suturing devices and systems provided herein have a diameter of between 0.5 cm to 4 cm.
- balloons used in balloon catheter suturing devices and systems provided herein have a diameter of between 1.0 cm to 2 cm.
- balloons used in balloon catheter suturing devices and systems provided herein can provide a field of view of between 0.5 cm to about 3 cm. In some cases, balloons used in balloon catheter suturing devices and systems provided herein can provide a field of view of between 1.0 cm to about 2.0 cm. In some cases, balloons used in balloon catheter suturing devices and systems provided herein can provide a field of view of about 1.5 cm. In some cases, the ratio of longitudinal balloon length versus diameter is approximately 1:1 with the camera's angle of view being about 30 degrees.
- Balloon 500, 520, 540, 560, 580, and 590 can be a compliant balloon that fills with an inflation media, which inflates balloon from a smaller deflated size to a larger inflated size thus allowing a larger device to be transferred through the catheter.
- Balloon 500, 520, 540, 560, 580, and 590 can be adapted to be filled with inflation media supplied through one or more lumens of a tubular body, e.g., tubular body 112 of FIG. 1 , from a fluid source that connects to a manifold at a proximal end of tubular body 112.
- balloon 500, 520, 540, 560, 580, and 590 can be filled with inflation media, e.g., saline solution, to facilitate visualization through camera, e.g., camera 207 of FIG. 2 , at a distal end portion of a direct visualization catheter.
- Balloon 500, 520, 540, 560, 580, and 590 can facilitate visualization in several ways.
- balloon 500, 520, 540, 560, 580, and 590 can be used to visualize anatomical features within the anatomy when pressed against a targeted anatomical feature and inflation media flows out of pores to clear an exterior surface of balloon of blood.
- balloon 500, 520, 540, 560, 580, and 590 can be composed of materials that are optically transparent when exposed to a particular inflation media and/or bodily fluids.
- Balloon 500, 520, 540, 560, 580, and 590 as well as other medical device components, can be constructed of various materials that are optically transparent when exposed to inflation media, e.g., saline solution, and/or bodily fluids, e.g., blood.
- inflation media e.g., saline solution
- bodily fluids e.g., blood
- balloon 500, 520, 540, 560, 580, and 590 can be constructed of various transparent materials that maintain transparency within the body over a desired duration.
- suitable balloon materials can have anti-fouling properties, e.g., materials resistant to protein-binding and platelet adsorption, which maintain transparency over longer durations than materials that are do not have anti-fouling properties.
- fouling generally refers to a material that undesirably accumulates foulants, such as biomacromolecules, microorganisms, hydrocarbons, particles and colloids, from the surrounding environment.
- Anti-fouling properties also referred to as a "stealth effect," reduces intermolecular forces of interactions between foulants and the balloon material.
- balloon materials can have anti-thrombogenic properties to prevent the formation of clots in the body.
- balloon 500, 520, 540, 560, 580, and 590 can include a hydrophilic material. Hydrophilic materials can allow the saline to preferentially be wet over allowing the air to contact the surface. In some cases, any air bubble which may occur in the balloon can be flushed out of the field of view or broken up.
- Balloon 500, 520, 540, 560, 580, and 590 may be constructed of various materials having physical, mechanical or functional properties that can improve device performance. Furthermore, these various materials can be incorporated at specific locations of the balloon where specific functional properties are desired.
- balloon 500, 520, 540, 560, 580, and 590 can be constructed of various materials that are self-healing. Self-healing refers to a structural ability of a material, e.g., fiber-reinforced polymers, to repair mechanical damage.
- balloon 500, 520, 540, 560, 580, and 590 may be constructed of various materials having suitable mechanical properties, such as tensile strength, ductility and elastic modulus.
- At least a portion of a balloon material can have a Shore A hardness of 90 or less to provide the balloon with suitable flexibility.
- balloon 500, 520, 540, 560, 580, and 590 can be constructed of various materials having suitable lubricity. Lubricity can help facilitate proper balloon placement within the anatomy and minimize blood vessel and tissue damage otherwise caused by balloon 208 or alternative medical devices.
- FIGS. 6A-6D depict an exemplary balloon camera view of a balloon 610 including a pledget section 646 in a balloon wall 611 defined by tear off notches in the balloon wall.
- FIG. 6A depicts the balloon 610 prior to having a fastener 624 (e.g., a staple or a suture) passed through the pledget section 646 and into tissue surrounding the pledget detachable section 646.
- FIG. 6B depicts the balloon 610 having pledget detachable section 646 sutured by fastener 624 (e.g., a staple or a suture) to tissue on an exterior surface of the pledget detachable section 646.
- FIG. 6C shows the balloon 610 having a hole 658 from where the pledget detachable section 646 was removed, and FIG. 6D depicts the sutured pledget 656.
- FIGS. 7A-7C illustrate a camera view showing how detachable sections 746 can be sutured to an anatomical location and separated from balloon 710.
- a balloon 710 can include pledget detachable sections 746 and a through working channel 722, through which a suturing thread rides with a fastening tool (not shown).
- the fastening tool working channel 722 can be a central hole or pore in balloon 710.
- each pledget detachable section 746 includes tear notches 747.
- a suture thread 712 can be passed into working channel 722 by a fastening tool (not shown), piercing tissue outside of balloon 710 and piercing pledget detachable section 746 of the wall of balloon.
- a fastening tool not shown
- balloon 710 can be moved or retracted to separate the sutured pledget 756 from the balloon 710.
- multiple pledget detachable sections 746 are sutured to different anatomical locations prior to separating the pledget detachable sections 746 from balloon 710 to product sutured pledgets 756.
- the pledget detachable sections 746 are laminated to an outer surface of the balloon wall such that removal of pledget 756 does not produce a pledget sized hole in balloon 710. In some cases, pledget detachable sections 746 are defined by a weakened score line to produce a tear line around pledget detachable sections 746.
- FIGS. 9A-9C show cross-sectional views of various examples of tubular bodies 900, 920, 940, which can be used in balloon catheter suturing devices and systems provided herein.
- tubular body 900 includes a plurality of lumens that includes a central lumen 902 and a plurality of non-central, surrounding lumens 904.
- Plurality of non-central, surrounding lumens 904 of FIG. 9A includes four circular surrounding lumens 906 and one rectangular surrounding lumen 908.
- Central lumen and surrounding lumens can be formed of various sizes and shapes. For example, as shown in FIGS. 9A , central lumen 902 can be larger than some or all non-central, surrounding lumens 904.
- tubular body 900 may have only non-central, surrounding lumens 904, i.e., no central lumen. In some cases, tubular body may have one lumen or multiple lumen, for example, up to 15 lumens.
- tubular body 920 includes a plurality of lumens that includes a central lumen 922 and plurality of non-central, surrounding lumens 924.
- Plurality of non-central, surrounding lumens 924 of FIG. 9B includes three circular surrounding lumens 926, one rectangular surrounding lumen 928, and six slot-shaped lumens 930.
- tubular body 940 includes a plurality of lumens that includes a central lumen 942 and plurality of non-central, surrounding lumens 944.
- Plurality of surrounding lumens 944 of FIG. 9C includes three circular surrounding lumens 946, one rectangular surrounding lumen 948, and six curvilinear, slot-shaped lumens 950.
- Balloon catheter suturing devices and systems provided herein may include a balloon constructed of one or more polymeric, transparent materials.
- the balloon can be constructed of a polymeric fibrous matrix or a polymer film.
- the balloon is constructed of a modified thermoset polymer (also described as a composite of polymeric fibers and polymers).
- FIG. 10 shows a cross-sectional view of a balloon material that includes a modified thermoset polymer 1000.
- polymer 1000 includes an inner layer 1002 (which may also be referred to as a first layer) and an outer layer 1004 (which may also be referred to as a second layer).
- Inner and outer layers 1002, 1004 of FIG. 10 each includes one or more polymeric materials.
- inner layer 1002 of FIG. 10 includes a thermoset polymer 1008 and a plurality of polymeric fibers 1010 (represented by crosshatch lines in the figure) embedded within thermoset polymer 1008.
- thermoset polymer 1008 is embedded with individual fibers that make up the plurality of polymeric fibers 1010.
- polymer 1008 can fully or partially fill space between some of the individual fibers. Described differently, thermoset polymer 1008 can interpenetrate the space between individual fibers that make up the plurality of polymeric fibers 1010. In some cases, thermoset polymer 1008 can covalently bond to the individual fibers. In some cases, polymer 1008 can mechanically engages with the individual fibers by interlocking with at least a portion of the plurality of polymeric fibers 1010.
- Exemplary materials of various thermoset polymers 1008 include, but are not limited to, polyurethanes, silicones, phenolic polymers, amino polymers, epoxy polymers and combinations thereof.
- FIGS. 11B-11D depict cross-sectional views of an exemplary composite that includes polymeric fibers embedded within a silicone thermoset polymer.
- Suitable silicones may include, but are not limited to, polydimethylsiloxane (PDMS), polydiphenylsiloxane, polymethylphenylsiloxane, fluorosilicones such as poly methyl(3,3,3-trifluoropropyl)siloxane and combinations thereof.
- the plurality of polymeric fibers 1010 of FIG. 10 can be randomly oriented. In such cases, the plurality of polymeric fibers 1010 may form a nonwoven fibrous matrix. In some cases, the plurality of polymeric fibers 1010 can be oriented in a regular pattern. The plurality of polymeric fibers 1010 oriented in a regular pattern may form a woven fibrous matrix.
- the nonwoven fibrous matrix can provide the benefit of providing multiaxial strength to a material while the woven fibrous matrix can provide uniaxial strength directed to a particular axis.
- Polymeric fibers can be constructed of biocompatible materials including various thermoplastic materials.
- fibers may be formed of thermoplastic materials suitable for electrospinning, force spinning or melt-blowing processes.
- Electrospinning is a process that uses electrical charge to create fibers from a liquid while force spinning is a process that uses centrifugal force to create fibers.
- Melt-blowing is a process in which a molten thermoplastic resin is extruded through a die and then stretched and cooled with high-velocity air to form long, fine fibers.
- fibers can be constructed of various polymers that exhibit hydrophilic or hydrophobic characteristics.
- fibers can be raw e-spun fibers, such as those shown in FIG. 11A .
- Suitable polymers for fibers can be formed from fluoropolymers including, but not limited to, for example, polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF) (e.g. KynarTM and SolefTM), poly(vinylidene fluoride-co-hexafluoropropene) (PVDF-HFP), cyclic fluoropolyethers such as CytopTM, perfluoroalkoxy alkane resins (PFA), poly(pentafluorostyrene), poly(2,2,3,3,4,4,4-heptafluorobutyl methacrylate), fluoroethylene-alkyl vinyl ether (FEVE; Lumiflon(TM)), poly[4,5 difluoro 2,2 bis(trifluoromethyl)-1,3-dioxole-co-tetrafluoroethylene, and combinations thereof.
- PTFE polytetrafluoroethylene
- PVDF polyvinyliden
- urethane-based polymers that include, but are not limited to, for example, polyurethanes, polyurethane elastomers (e.g. Pellethane), polyether-based polyurethanes (e.g. Tecothane), polycarbonate-based polyurethanes (e.g. Bionate and/or Chronoflex) and combinations thereof.
- suitable polymer materials for fibers can include, but are not limited to, polycarbonate, polyether, polyester, polyamide, nylon 6, nylon 12,, nylon 66, nylon 10, nylon 11, polyetherimide and combinations thereof.
- fibers are formed from block polymers such as, for example, a poly(styrene-b-isobutylene-b-styrene) (SIBS) tri-block polymer and/or a polyisobutylene polyurethane (PIB-PUR).
- SIBS poly(styrene-b-isobutylene-b-styrene)
- PIB-PUR polyisobutylene polyurethane
- Polymeric fibers can have diameters in the range of about 40 nanometers (nm) to 10,000 nm, for example.
- the fiber diameter size can include a range of about 100 nm to 3,000 nm.
- suitable fiber diameter sizes can include ranges of about 40 nm to 2,000 nm, about 100 nm to 1,500 nm or about 100 nm to 1,000 nm, for example.
- fibers 412 can have average fiber diameters ranging between about 900 nm to 10,000 nanometers or between about 800 nm to 10,000.
- fibers 912 are nanofibers having diameters less than 1,000 nm.
- nanofiber diameters can range from about 100 nm to 800 nm, or be any value there between.
- nanofiber diameters can range from 100 nm to 400 nm.
- Outer layer 1004 of FIG. 10 can include one or more hydrogels (also described as crosslinkable, hydrophilizing agents). Hydrogels are a network of hydrophilic polymer chains that are bonded together by association bonds, such as hydrogen bonds and intermolecular hydrophobic associations. Hydrogels have structures that are capable of retaining large amounts of water.
- outer layer 1004 includes hydrogels that are optically transparent in vivo, i.e., when placed into a body.
- outer layer 1004 includes hydrogels having anti-fouling properties, for example, are resistant to protein binding and platelet adsorption.
- hydrogels are anti-thrombogenic. Material having anti-fouling properties provide the advantage of being optically transparent for longer durations in vivo. Anti-thromobogenic materials provide implantable components and devices with a benefit of long-term biocompatibility in vivo.
- Suitable hydrogels include, but are not limited to, olefin based polymers such as a polyethylene glycol (PEG) or a PEG derivative, for example, PEG-dimethacrylate, UV-curable PEG, PEG diacrylate, polyethylene glycol-neopentyl glycol diacrylate methyl acrylate (PEG-NPDGA), PEG-BioslideTM, PEG-Z-GlideTM, chitosan-PEG, thiol-PEG, maleimide-PEG, amino-PEG, azide-PEG, and carboxyl-PEG.
- PEG polyethylene glycol
- PEG derivative for example, PEG-dimethacrylate, UV-curable PEG, PEG diacrylate, polyethylene glycol-neopentyl glycol diacrylate methyl acrylate (PEG-NPDGA), PEG-BioslideTM, PEG-Z-GlideTM, chitosan-PEG, thi
- hydrogels examples include, but are not limited to, polyvinylpyrrolidone (PVP), polyvinyl acetate (PVA), glycosaminoglycans (e.g. heparin), poly [N-(2-hydroxypropyl) methacrylamide] (PHPMA), poly(vinyl pyrrolidone), polyethylene/oligoethylene, polyHEMA, polytetraglyme, hyaluronic acid, chitosan and any derivatives thereof.
- PVP polyvinylpyrrolidone
- PVA polyvinyl acetate
- glycosaminoglycans e.g. heparin
- PPMA poly [N-(2-hydroxypropyl) methacrylamide]
- PVP poly(vinyl pyrrolidone)
- polyethylene/oligoethylene polyHEMA
- polytetraglyme polytetraglyme
- hyaluronic acid chitosan and any derivatives thereof.
- the hydrogel is embedded with a plurality of polymeric fibers 1010.
- the hydrogel can covalently bond to individual fibers that make up the plurality of polymeric fibers 1010.
- the hydrogel can bond to individual fibers by chemical association bonding, such as hydrogen bonding and/or intermolecular hydrophobic associations.
- the hydrogel can mechanically engage with at least a portion of the plurality of polymeric fibers 1010 by interpenetrating space between individual fibers protruding from a surface of an adjacent layer.
- the plurality of polymer fibers 1010 is partially embedded in a portion 1012 of outer layer 1004 located adjacent the inner layer 1002.
- the hydrogel can also be incorporated with a polymer solution from which spun fibers are formed. As a result, hydrophilic polymer chains can be intertwined or entangled with another polymer.
- selection portions of the different layers shown in FIGS. 10 and/or 11B-11D can be treated to create weakened portions of the balloon to create tear lines for separating a pledget section of a balloon wall.
- the polymeric fiber layers can have be cut along desired tear lines prior to combining the fibers with the thermoset polymer.
- FIG. 12A is a flowchart of an example method 1200 of manufacturing balloons provided herein, such as balloon 108, 208, 310, 410, 618, 500, 520, 540, 560, 580, and 590, 1810, 1910, or 2010.
- An initial set of operations 1211, 1212, 1213 forms an inner layer of balloon and any subsequent operations 1214 forms an outer layer of balloon.
- a plurality of polymeric nanofibers are formed into an interior cavity of a balloon mold using an electrospinning process. In some cases, the electrospinning process can leave sections uncovered to produce weakened sections.
- a plurality of polymeric nanofibers can be preformed into a thin, nonwoven fibrous matrix film or sheet.
- a thin, nonwoven fibrous matrix film or sheet can have score lines cut into to produce weakened tear lines.
- nanofibers may be constructed using processes other than the electrospinning process, for example, a force spinning process.
- a curable thermoset material e.g. polydimethylsiloxane (PDMS)
- PDMS polydimethylsiloxane
- thermoset material is cured to form a pre-formed balloon.
- pre-formed balloon is removed from balloon mold and an exterior surface of the pre-formed balloon is treated with a crosslinkable, hydrophilizing agent, such as PEG-dimethacrylate, described herein.
- a crosslinkable, hydrophilizing agent such as PEG-dimethacrylate, described herein.
- the hydrophilized balloon may continue on to other manufacturing operations to build a direct visualization catheter or an alternative medical device.
- FIG. 12B is a flowchart of another example method 1200 of manufacturing balloons provided herein, such as balloon 108, 208, 308, 408, 500, 520, 540, 560, 580, and 590, or an alternative tubular component.
- An initial set of operations 1210, 1220, 1230 forms an inner layer of balloon and operation 1260 forms an outer layer of balloon.
- thermoset material is injected into a balloon mold using a curable thermoset material and only partially cured.
- a plurality of polymeric nanofibers are formed onto partially cured thermoset material using an electrospinning process or alternative process, such as force spinning. Because thermoset material is not fully cured, at least a portion of plurality of polymeric nanofibers penetrates into thermoset material such that nanofibers are exposed at an exterior surface of balloon. In some cases, the electrospinning process and/or the force spinning process can arrange the delivery of fibers to create weakened tear lines in a resulting balloon.
- thermoset material is cured to form an inner layer of a pre-formed balloon.
- Thermoset material may be cured as described herein.
- pre-formed balloon is optionally removed from balloon mold and, at operation 1250, per-formed balloon is inverted such that at least a portion of plurality of polymeric nanofibers are exposed along an exterior surface of balloon.
- operation step 1250 may not be necessary if during operation, at least a portion of the plurality of polymeric nanofibers penetrates into thermoset material such that fibers would be exposed at exterior surface of a non-inverted balloon
- exterior surface of the pre-formed balloon is treated with a crosslinkable, hydrophilizing agent, e.g., PEG-dimethacrylate, described herein.
- a hydrophilized balloon may continue on to other manufacturing operations, if applicable.
- FIG. 13 is a flowchart of another example method 1300 of manufacturing balloons provided herein, such as balloon 108, 208, 308, 408, 500, 520, 540, 560, 580, 590, or an alternative tubular component.
- An initial set of operations 1310, 1320, 1330 forms an inner layer of balloon and subsequent operation 1340 forms an outer layer of balloon.
- a curable thermoset material e.g. polydimethylsiloxane (PDMS)
- PDMS polydimethylsiloxane
- the mandrel can be formed in various balloon shapes or tubular shapes.
- a plurality of polymeric nanofibers are formed on a shaped mandrel using an electrospinning process or a force spinning process.
- the plurality of polymeric nanofibers are formed onto thermoset material such that at portion of the nanofibers penetrates into thermoset material and another portion of the nanofibers remains exposed at an exterior surface of the balloon.
- the electrospinning process and/or the force spinning process can arrange the delivery of fibers to create weakened tear lines in a resulting balloon.
- thermoset material is fully cured to form an inner layer of a pre-formed balloon.
- Thermoset material may be cured as described herein.
- the pre-formed balloon is treated with a crosslinkable, hydrophilizing agent, such as PEG-dimethacrylate, described herein.
- a hydrophilized balloon may be removed from the mandrel at any time after thermoset material has been cured. Hydrophilized balloon may be subject to subsequent manufacturing operations to build a direct visualization catheter or an alternative medical device.
- FIG. 14 is a flowchart of a method 1400 for securing a pledget and fastener to a target area, e.g., a left atrium of a heart, during a surgical procedure using a balloon catheter suturing system in accordance with some of the embodiments provided herein.
- a target area within a patient can be located and initially inspected by advancing at least a portion of the balloon catheter suturing system to the target area.
- balloon catheter suturing system or portions thereof, e.g., a visualization portion is advanced to the target area to provide visual or ultrasound images of the target area.
- the balloon catheter suturing system or portions thereof can be advanced to the target area over a guidewire or within a guide catheter. Once at the target area, the balloon catheter suturing system or portions thereof can provide direct visual images or ultrasound images for the inspection. In some cases, inspection can also include injecting contrast media into the targeted area and viewing the area using fluoroscopic equipment.
- the balloon catheter suturing system is advanced to the target area and a portion thereof expanded at the target area to stabilize the balloon catheter suturing system.
- a balloon or stent is expanded to stabilize the balloon catheter suturing system.
- a desired surgical location at the target area can be verified by using direct visual or ultrasound imaging provided by the balloon catheter suturing system.
- a primary camera located in balloon or stent portion of catheter can be used to verify the surgical location.
- the balloon catheter suturing system includes a secondary visualization portion that can be used in conjunction with the primary camera to visually verify the surgical location.
- primary camera may provide anterior visual images and the secondary visualization portion may provide posterior visual images.
- the balloon catheter suturing system can be manipulated such that a pledget or pledget section of a balloon is positioned near or at the desired surgical location.
- a distal end portion of direct visualization catheter can be deflected at a specific angle to position one or more pledgets in a desired location.
- a select portion of direct visual catheter is advanced to the desired location.
- the tissue is pierced using a fastening tool.
- a portion of the balloon catheter suturing system e.g., a needle, can be used to pierce tissue at the surgical location.
- the balloon catheter suturing system can advance a fastener, such as a staple or clasp, such that the fastener pierces the tissue at the surgical location and a pledget section of a balloon.
- the advancement of the fastener can interlock the fastener with a pledget.
- fastener is attached to tissue and the pledget or pledget section of a balloon.
- attaching the fastener to tissue can include securing a suture through tissue at the surgical location and through a hole in a pledget.
- attaching fastener to tissue can include attaching a pledget, staple or clasp to tissue at the surgical location through a pledget section of a balloon wall.
- the fastener and pledget are released from the balloon catheter suturing system.
- a pledget section of a balloon wall is torn away from the balloon by retracting the balloon.
- the pledget is released from the catheter using an actuator at a proximal end of the balloon catheter suturing system.
- fastener is released from the catheter using an actuator at a proximal end of the balloon catheter suturing system.
- pledget and/or fastener is released from the catheter by advancing a portion of the catheter, e.g., a pusher rod, to push the fastener away from a distal end of the catheter.
- pledgets and/or fastener such as a suture thread, may not be released from the catheter until multiple surgical areas have been secured with the fasteners and pledgets.
- FIG. 15 shows an exemplary fastening tool 1500, which can be used in balloon catheter suturing systems provided herein.
- Fastening tool 1500 includes a tubular main body 1502 with a distal end portion 1504, a proximal end portion 1506, and a lumen (not shown) therethrough that is sized to receive a fastener 1508.
- tubular main body 1502 can be generally straight.
- a portion of tubular main body 1502, e.g., a distal end portion 1504 can be pre-formed to bend at a suitable angle or have a curvature that allows fastening tool 1500 to better access target tissue areas during a surgical procedure.
- tubular main body 1502 can be deflectable such that the distal end portion 1504 can deflect to different angles during the procedure.
- Distal end portion 1504 of fastening tool 1500 includes a distal end 1514 and defines a distal opening 1516 adapted to receive and temporarily retain fastener 1508. As shown in FIG. 15 , in some cases, opening 1516 is adapted to retain a ring-shaped fastener 1508.
- Fastening tool 1500 can be coupleable to various types of fasteners 1508, for example, suture, a suture with a pledget, clips, and/or staples. Fastening tool 1500 can be used to deliver and affix fastener 1508 to tissue, e.g., annulus of a heart valve.
- Proximal end portion 1506 can include a proximal end 1518 and defines a proximal opening 1520 adapted to receive fastener 1508.
- proximal end portion 1506 has a sleeve 1522 adapted to receive at least one rod, e.g., a push rod 1524 and/or an insertion rod 1526.
- Insertion rod 1526 can be used to load fastener 1508 into sleeve 1522.
- Push rod 1524 can be used to advance fastener 1508 through sleeve 1522 into tubular main body 1502.
- Push rod 1524 can be sized and shaped to be received through a lumen (not shown) of tubular main body 1502 and be extended from distal opening 1516. In some cases, a single rod can be used as both push rod 1524 and insertion rod 1526.
- FIGS. 16A-16C show cross-sectional views of an exemplary fastening tool 1600, which can be used in balloon catheter suturing systems provided herein, at a distal end portion 1602.
- Fastening tool 1600 can include a tubular body 1604 defining a lumen 1606 adapted to receive a fastener 1608, e.g., an annulus clasp, and a distal end 1610 defining a distal opening 1612.
- fastener 1608 can be advanced through distal end portion 1602 of fastening tool 1600 and released from fastening tool 1600 at distal opening 1612.
- Lumen 1606 can be sized and shaped to receive fastener 1608.
- Lumen can also be sized and shaped to receive at least a portion of a push rod 1614.
- Push rod 1614 can be used to about a proximal end 1616 of fastener 1608 and be translated distally to push fastener 1608 to distal end 1610 of fastening tool 1600.
- Distal opening 1612 can be adapted to allow fastener 1608 to pass through.
- distal end 1610 can include a sensor 1618 that indicates when fastener 1608 has reached distal opening 1612. Sensor 1618 can provide location information of fastener 1608 to indicate when fastener 1608 is ready to be released from fastening tool 1600. Sensor 1618 may also be used to prevent accidental release of fastener 808.
- push rod 1614 and fastener 1608 are located at distal end portion 1602 of fastening tool 1600 proximate to distal opening 1612.
- push rod 1614 and fastener 1608 are distally translated such that distal end 1620 of fastener 1608 begins to emerge from distal opening 1612.
- distal end 1620 of fastener 1608 can begin to form into a preformed shape, e.g., begin to curl into a ring-like clasp.
- push rod 1614 is further distally translated such that fastener 1608 extends from distal opening 1612 in a partially deployed state. As shown in FIG.
- fastener 1608 can curl into a semi-circular shape in partially deployed state.
- Fastener 1608 can be fully deployed to form a full ring by further distally translating push rod 1614 such that fastener extends completely from distal opening 1612.
- Fastener 1608 can be transitioned from the partially deployed state to the fully deployed after the device has been properly positioned at a target surgical location.
- Fastener 1608 can be fastened to tissue when transitioned from the partially deployed state to the fully deployed state.
- sensor 1618 can be used to identify that fastener 1608 is ready to be fully deployed prior to being released from fastening tool 1600.
- FIGS 17A-17G show various exemplary fasteners 1700, 1710, 1720, 1730, 1740.
- fasteners can be formed of various shapes and sizes. Suitable types of fasteners include, but are not limited to, for example, a suture, staple, hook, tack, clamp or a clip. Fasteners can be made of various polymeric and metallic materials. Suitable materials for fasteners include, but are not limited to, for example, polyethylene, polypropylene, polycarbonate, PEEK, stainless steel, nitinol and combinations thereof.
- fastener 1700, 1710 can be a single body 1702, 1712 with sharp tips 1704, 1714 adapted to penetrate tissue on each end.
- body 1702 of fastener 1700 can define at least one thru-hole 1706.
- thru-hole can be sized to receive a suture (not shown).
- a single body fastener 1700, 1710 can be reshaped such that sharp tips 1704, 1714 can be easily joined together and attached to tissue.
- fastener 1720, 1730 can include two or more portions coupled together by a hinge connector 1722, 1732 that allows tissue penetrating tips 1724, 1734 to join together. Possible fastener designs are not limited by the examples provided herein, as one skilled in the art could contemplate other various structures that could be used to penetrate tissue and/or connect suture to tissue.
- FIGS. 17E-17G show another exemplary fastener 1740 that can be formed of a single body 1742 that can be shaped into multiple configurations.
- Fastener 1740 can be shaped in a first configuration (see FIG. 17E ) prior to implantation and a second configuration (see FIG. 17F and 17G ) during and after implantation.
- fastener 1740 can be made of a shape memory material or a malleable material.
- Fastener 1740 can be made of various shape memory metals or polymers and be pre-formed into a desired final shape.
- fastener 1740 can be fixed into second configuration by a connector, such as a clip 1741, as shown in FIG. 17G .
- fastener can be shaped as a flat segment 1744 in first configuration when being delivered by a direct visualization catheter (or a direct visualization system) to a surgical site.
- Fastener can form into the desired final shape, e.g., a ring-like clasp 1746 as shown in FIGS. 17F and 17G , in second configuration when implanted into a patient.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pulmonology (AREA)
- Manufacturing & Machinery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgical Instruments (AREA)
- Endoscopes (AREA)
Description
- This disclosure relates to balloon catheters suturing systems, methods, and devices. For example, balloon catheter suturing systems, methods, and devices provided herein can include pledgets.
- Heart function can be significantly impaired when a heart valve is not performing properly. Potential causes for heart valve malfunction include dilation of an annulus around the valve, ventricular dilation, and a prolapsed or misshapen valve leaflet. When the heart valve is unable to close properly, blood within a heart chamber can leak backwards, through the valve, which is commonly referred to as regurgitation. Valve regurgitation may be treated by replacing or repairing a diseased valve. The most common method of correcting tricuspid valve regurgitation is to reduce the annulus by bringing the anterior and septal leaflets closer together using sutures. In some cases, precut sheet pieces of polytetra-fluorethylene (PTFE), also known as pledgets, are used with the sutures to cushion the load of the suture against host tissue.
- Although open heart surgery is one method for treating the diseased valve, a less invasive methods of treatment would be more desirable for many patients. Minimally invasive procedures, however, are significantly limited by the lack of adequate visualization through blood within a patient's beating heart. Accordingly, there is a need for alternative devices and methods for treating heart valve disease that provides adequate visualization and suture delivery for users during a minimally invasive procedure.
EP2508222A1 discloses an apparatus for delivering a therapeutic and/or diagnostic agent to tissue within a bodily cavity. The apparatus may include a catheter assembly including a catheter and a delivery balloon having an expandable material disposed thereon, wherein the expandable material may be an absorbent at least partially charged with a therapeutic and/or diagnostic agent. - The present invention is defined by the features of the claims.
- Balloon catheter suturing systems provided herein can be used to suture one or more anatomical locations using less invasive techniques while providing visualization of the anatomical location.
- In accordance with an embodiment, balloon catheter suturing systems provided herein include an elongate shaft defining a lumen and having a distal end portion and a proximal end portion, a balloon attached to the distal end portion, and at least a first pledget secured to the balloon by a portion of the balloon catheter suturing system adjacent the balloon. The balloon catheter suturing system includes at least one fastener adapted to fasten the first pledget to an anatomic structure when the balloon catheter suturing system is positioned within a patient. The balloon is a weeping balloon.
- In some cases, the first pledget is part of the transparent wall. In some cases, the first pledget is held by an internal pledget support structure within the transparent wall of the balloon. In some cases, the first pledget is held by a first pledget support structure outside the transparent wall of the balloon distal to the balloon.
- In some cases, balloon catheter suturing systems further comprise a second pledget held by a second pledget support structure proximal to the first pledget, wherein at least one fastener is adapted to fasten the first and second pledgets together on opposite sides of the anatomic structure. In some cases, the second pledget is positioned within the transparent wall of the balloon. In some cases, the second pledget is positioned outside of the transparent wall.
- In some cases, the first pledget is defined by weakened sections defining one or more tear lines around the first pledget in the transparent wall. In some cases, the first pledget is adapted to delaminate from a portion of the transparent wall. In some cases, the transparent wall comprises at least a first layer comprising a thermoset polymer and a plurality of polymeric fibers at least partially embedded in the thermoset polymer. In some cases, the transparent wall comprises at least a second layer disposed on the first layer, wherein the second layer comprises a hydrogel.
- In some cases, the balloon catheter suturing system can include a transparent wall including at least a first layer comprising a thermoset polymer and a plurality of polymeric fibers at least partially embedded in the thermoset polymer. In some cases, the transparent wall can include at least a second layer disposed on the first layer. In some cases, the second layer can include a hydrogel. In some cases, the polymeric fibers can be electrospun fibers randomly oriented within the thermoset polymer. In some cases, the thermoset polymer comprise a silicone, such as polydimethylsiloxane (PDMS).
- The balloon catheter suturing system can have any suitable balloon shape. In some cases, the balloon can be configured such that sutures are passed through the balloon. In some cases, the balloon can define a working channel there through. The balloon is a weeping balloon.
- In some aspects, a method for repairing a heart valve in a patent can include advancing a balloon end of a balloon catheter into an atrium of a heart, imaging a portion of a heart valve, passing a suture through at least one detachable section to suture a portion of the heart valve to the at least one detachable section, and separating the at least one detachable section from the balloon catheter. The balloon catheter can include one or more elongate shafts in fluid communication with a balloon having a transparent wall. In some cases, the transparent wall can define the at least one detachable section. In some cases, the transparent wall can define multiple detachable sections. In some cases, a portion of a heart valve is imaged through the transparent wall using an imaging element disposed within the balloon through the one or more elongate shafts. In some cases, the at least one detachable section is separated from the balloon catheter by deflating the balloon and removing the balloon catheter from the heart. In some cases, the transparent wall defines the one or more detachable sections with weakened tear lines that tear when the balloon is removed from the heart. In some cases, a plurality of sutures are attached to multiple parts of a heart valve through a plurality of detachable sections prior to separating the plurality of detachable sections. In some cases, the heart valve is a tricuspid valve. In some cases, a valve annulus is sutured to the at least one detachable section.
- The details of one or more embodiments of direct visualization devices, systems, and methods provided herein are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and drawings, and from the claims.
-
-
FIG. 1A is an illustration of an exemplary balloon catheter suturing system within a human anatomy.FIG. 1B is a perspective view of a distal end portion of an exemplary balloon catheter having detachable pledgets. -
FIG. 2 is a perspective view of a distal end portion of another exemplary balloon catheter having a detachable pledget. -
FIGS. 3A-3J depict another exemplary balloon catheter suture delivery system having a pair of pledgets disposed distal to the balloon.FIG. 3A depicts a distal end of the system.FIGS. 3B and 3C depict a controlling handle for the system.FIGS. 3D-3I depict the system being used to suture the valve annulus of a tricuspid valve.FIG. 3I depicts the pledgets and suturing thread in isolation. -
FIG. 4 depicts another exemplary suture system that can be used with a balloon catheter suture delivery system provided herein. -
FIGS. 5A-5F show several examples of a balloon shapes that can be used in balloon catheter suturing devices and systems provided herein. -
FIGS. 6A-6D depict how an exemplary balloon catheter suturing system provided herein can be used to suture tissue and leave a pledget. -
FIGS 7A-7C and 8A-8C depict how another exemplary balloon catheter suturing system provided herein can be used to suture tissue and leave pledgets. -
FIGS. 9A-9C show cross-sectional views of various examples of a tubular body that can be part of balloon catheter suturing devices and systems provided herein. -
FIG. 10 illustrates a cross-sectional view of a balloon material, which can be used in balloon catheter suturing devices and systems provided herein. -
FIG. 11A shows an e-spun fiber network.FIGS. 11B-11D are cross-sectional views of composite of silicone and polymeric fibers, which can be used in certain balloon catheter suturing devices and systems provided herein. -
FIGS. 12A-12B and 13 provide flowcharts of methods used for manufacturing balloon catheter suturing devices and systems provided herein. -
FIG. 14 is a flowchart of a method securing a fastener to tissue during a surgical procedure using balloon catheter suturing devices and system provided herein. -
FIG. 15 shows an exemplary fastening portion, which can be used with or in balloon catheter suturing devices and systems provided herein. -
FIGS. 16A-16C show cross-sectional views of an exemplary fastening portion at a distal end portion. -
FIGS. 17A-17G show various exemplary fasteners. - Balloon catheter suture devices, systems and methods provided herein include features that improve minimally invasive surgical techniques used during a heart valve repair procedure such as, but not limited to, procedures that suture one or more heart valve leaflets. Exemplary procedures include those that bicuspidizes a tricuspid valve, edge to edge stitching techniques (or Alfieri stitches), mitral valve stitches, closures of paravalvular leaks, percutaneous paravalvular leak closure, and/or percutaneous closure of prevalvular leaks. The term "suture" is used herein to refer to any fastening of anatomical structures, which can be made with any suitable fastener including suturing thread, clips, staples, hooks, tacks, clamps, etc.
- Balloon catheter suture devices, systems, and methods provided herein include pledgets retained at an external end of the balloon catheter suturing device. The pledgets are adapted to be sutured to an anatomical location, separate from the balloon catheter, and remain with a resulting suture. As used herein, the term "pledget" will refer to a piece of material that is intended be sutured to an anatomical location. In some cases, the wall of the balloon can include portions arranged to be sutured to an anatomical location through the transparent wall and to separate from the remainder of the balloon catheter to become a pledget. In some cases, balloon catheter suturing devices, systems, and methods provided herein can include one or more pledgets held by the balloon catheter suturing devices and systems provided herein and positioned inside and/or outside the balloon such that the pledget(s) can be secured to an anatomical location using one or more fasteners. In some cases, balloon catheter suturing devices, systems, and methods provided herein can include cooperating pledgets that are arranged to clamp around an anatomical structure have one or more fasteners passed there through.
- Balloon catheter suture devices, systems, and methods provided herein can allow for direct visualization of a target location, which can provide anatomy and pathology identification as well as device placement visual feedback to the physician user during a minimally invasive method. Balloon catheter suturing devices, systems, and methods provided herein can include an elongate, compliant balloon having a transparent wall. In some cases, the transparent wall can include portions arranged to be sutured to an anatomical location through the transparent wall and to separate from the remainder of the balloon catheter. In some case, the balloon can include pores to allow for the balloon to "weep" to provide a visually clear area surrounding the balloon. In some cases, the balloon wall (e.g., a transparent balloon wall) can have a structure that limits the propagation of tears. In some cases, as discussed below, the balloon all can include polymeric fibers within a matrix of a second material.
-
FIG. 1A shows an exemplary ballooncatheter suturing system 100 within a human anatomy. Ballooncatheter visualization system 100 can be inserted into a right atrium of a heart through a brachial vein or a jugular vein. As shown inFIG. 1A , ballooncatheter suturing system 100 includes an elongate shaft ortubular body 112 having aproximal end portion 114 with aproximal end 116 and adistal end portion 118 with adistal end 120.Proximal end portion 114 can couple to a manifold 122.Distal end portion 118 can include an integrated camera (not shown), afastening tool 124 with a fastener and at least one balloon 108 (also described as balloon member). Integrated camera andfastening tool 124 can be disposed withinballoon 108. As shown inFIG. 1A ,balloon 108 can form a distal tip of ballooncatheter suturing system 100. Thefastening tool 124 can pass a fastener through the balloon to suture an anatomical location outside the balloon. The balloon can be filled with an inflation medium, such as saline solution, that can be safely delivered to the patient, thus leakage from resulting holes in the balloon caused by the passing of the fastener through the balloon can be tolerated. - Balloon
catheter suturing system 100 can include apledget 126 located distal tofastening tool 124 such that a fastener delivered through the balloon is also delivered throughpledget 126 tosuture pledget 126 to an anatomical location.Pledget 126 can, in some cases, be a part of the balloon wall ofballoon 108 adapted to tear away from the balloon wall. In some cases,pledget 126 is laminated to an outside surface of the balloon wall. In some cases, a balloon wall can include weakened sections or weakened tear lines such thatpledget 126 tears away fromballoon 108 to leave a pledget sized hole. In some cases,pledget 126 can be held withinballoon 108. In some cases,pledget 126 can be held adjacent the exterior ofballoon 108. These different options are explained in further detail below. - In
FIG. 1A , ballooncatheter suturing system 100 includes at least onetubular body 112 defining a lumen (not shown). In some cases, ballooncatheter suturing system 100 can include multiple tubular bodies, in which each tubular body defines at least one lumen. Eachtubular body 112 can optionally include multiple lumens, for example, coaxial or non-coaxial lumens. Ballooncatheter suturing system 100 can have one or more lumens that extend partially or fully thorough one or moretubular bodies 112. One or more lumens can be used as a conduit adapted to receive components, e.g., integrated camera or fastener tools, and/or inflation media, e.g., saline. In some cases, one or more lumens can be adapted to jet inflation media, e.g., saline, intodistal end portion 118 of ballooncatheter suturing system 100. - Manifold 122 generally connects an external fluid supply to one or more lumens of balloon
catheter suturing system 100. Manifold 122 can include one or more ports 128 to facilitate a fluid connection to another medical device or a fluid source. For example, port 128 can supply saline solution into one or more lumens oftubular body 112. Manifold 122 may be coupled totubular body 112 directly or indirectly. In some cases, a flexible tubing, sometimes referred to as a strain relief tubing, is coupled between manifold 122 and thetubular body 112 at theproximal end 116 to provide a longitudinal tapered transition between manifold 122 andtubular body 112. Flexible tubing can help to increase kink resistance oftubular body 112 atproximal end portion 114. -
FIG. 1B depicts an distal end of exemplaryballoon catheter system 100 having aballoon 108 havingtear lines 196, or weakened sections, in theballoon wall 164 that definepledgets 126.Pledgets 126 are adapted to be sutured to anatomical locations and separated fromballoon 108. As shown inFIG. 1B , ballooncatheter suturing system 100 that includes an elongate,tubular body 112 with adistal end portion 154. InFIG. 1B , adistal end 156 ofdistal end portion 154 can be either directly or indirectly coupled to aballoon 108. For example,tubular body 112 can be coupled to balloon 108 indirectly by using anintermediate catheter shaft 157. As shown inFIG. 1B ,intermediate catheter shaft 157 couples to aproximal end 162 ofballoon 108 and acatheter interface portion 158 oftubular body 112. - In
FIG. 1B ,balloon 108 is disposed proximate todistal end 156 oftubular body 112.Balloon 108 can include theproximal end 162, a distal end 163 and awall 164 that extends from aninterior surface 165 to anexterior surface 166. As shown inFIG. 1B ,balloon 108 forms a distal tip 170 of ballooncatheter suturing system 100. As discussed herein,balloon 108 can be filled with an inflation media in aninterior cavity 168 defined between proximal anddistal ends 162, 163. Also discussed herein,balloon 108 can include a weeping balloon structure, i.e., a balloon structure that defines one ormore perforations 172 extending throughwall 164. - As shown in
FIG. 1B , distal end of tubular body can include a plurality of lumens 174. Each lumen of plurality of lumens 174 can longitudinally extend throughtubular body 112 entirely or partially there through. Each lumen can be formed from one of various cross-sectional shapes, e.g., circle, oval, slot, square, rectangular, triangular, trapezoid, rhomboid, or irregular shape. The shape of the lumen may facilitate receiving other components of ballooncatheter suturing system 100. For example, as discussed herein, one or more lumens 174 can be used to receive a fastening tool (not shown), acamera 176, fiber optic light cables (not shown), electrical cables (not shown), inflation media and combinations thereof. InFIG. 1B , tubular body can define acentral lumen 178 for receiving a fastening tool (not shown) for delivering a fastener (not shown), two lumens for receiving fiber optic light cables 180, one lumen for delivering inflation media 182, and one lumen for receivingcamera 176. -
Pledgets 126 can be sutured to an anatomical location and separated fromballoon 108 after suturing to become pledgets. In some cases,pledgets 126 are laminated onto the wall ofballoon 108 such that a resulting hole from the separation of the pledget is limited to the size of fasteners passed through the wall ofballoon 108. In some cases,pledgets 126 can be defined by weakenedsections 196 of the balloon wall surrounding eachpledget 126 such that detachment of eachpledget 126 creates a pledget sized hole inballoon 108. In some cases,pledgets 126 can each be secured to anatomical locations prior to separation. In some cases, an inflation medium flow can be reduced or stopped prior to separation. -
Balloon 108 of ballooncatheter suturing system 100 can be a weeping balloon. Weeping balloon, in the context of the present disclosure, includes a balloon structure defining one or more perforations (also described as apertures or micropores, extending through a balloon wall). As such, weeping balloons can transfer inflation media through the balloon wall, from interior cavity to exterior surface ofballoon 108. Transferring inflation media to exterior surface can provide a benefit of displacing blood from exterior surface ofballoon 108 that would otherwise blur or obstruct visual imaging throughballoon 108. In other words, inflation media transferred through the one or more perforations can help keep the exterior surface visually clear. If you just put a balloon against an anatomical surface, blood can be trapped on the balloon surface and thus obscures the view, but inflation media (e.g., saline) exiting the pores of a weeping balloon can wash away this blood on the balloon surface adjacent to the wall. In some cases, a weeping balloon used in a balloon catheter suturing system or device provided herein can have at least 3 punctured holes. In some cases, weeping balloons used in balloon catheter suturing systems or devices provided herein can have between 3 and 10,000 punctured holes, between 3 and 1,000 punctured holes, between 3 and 100 punctured holes, or between 3 and 10 punctured holes. In some cases, the number and dimensions of punctured holes in a weeping balloon used in a balloon catheter suturing system or device provided herein allows for an inflation media flow rate of between 1 and 50 ml/minute. In some cases, systems and methods provided herein control an inflation media flow rate to be between 3 ml/minute and 10 ml/minute. In some cases, a weeping balloon used in balloon catheter suturing systems and devices provided herein can have hundreds of holes that perfuse inflation media (e.g., saline) through the balloon and into the blood. In some cases, a weeping balloon used in a balloon catheter suturing system or device provided herein can have a greater pore density in portions of the balloon wall in the center of the field of view and a lower pore density around a periphery of the field of view. -
FIG. 2 is a perspective view of another example of a ballooncatheter suturing system 200. As shown, ballooncatheter suturing system 200 includes atubular body 202 withdistal end portion 204, apledget 206,suturing thread 212, and anintegrated camera 207 disposed within aballoon 208. - In
FIG. 2 ,pledget 206 is held distal to balloon 208 by apledget support 205 that extends adjacent theballoon 208 from alumen 209 at a distal end 219 oftubular body 202 withinballoon 208 while another portion offastening element 206 extends adjacent to balloon 208. As shown inFIG. 2 , a portion ofpledget support 205 extends around and distal to balloon 208 such thatpledget 206 forms adistal tip 218 of ballooncatheter suturing system 200. In some cases,multiple pledgets 206 can be included. In some cases, a portion ofpledget 206 can extend through theballoon 208. In some cases, a portion ofpledget 206 that is disposed withininterior cavity 214 can be subsequently extended through a wall ofballoon 208 to an exterior environment during a medical procedure. - Balloon
catheter suturing system 200 can include afastening tool 210 adapted to penetrate tissue, separate tissue, and/or deliver afastener 212 through the pledget and tissue, to secure a suture to tissue and/or to attach two pieces of tissues together. As shown,fastener 212 is suturing thread. In some cases,fastening tool 210 can be in the form of, for example, a needle, knife, scalpel, cutter and combinations thereof. In some cases, staple, hook, tack, clamp, a clip, or other suturing devices can be used instead of or withsuturing thread 212. - As shown in
FIG. 2 ,integrated camera 207 is disposed at the distal end 219 oftubular body 202 to provide visual imaging of a patient's anatomy during the medical procedure.Camera 207 may be fully or partially disposed within alumen 220 defined bytubular body 202. The camera can be coupled to electrical and/or optical cables (not shown) inlumen 220 that extend longitudinally throughtubular body 202 towards a proximal end portion oftubular body 202. In some cases,camera 207 is electrically connected to the external electronics with wires throughlumen 220. In some cases, a bundle of fiber optic cables, each with their own lens (e.g., borescopes), can be connected to an eyepiece for viewing or a camera for electrical conversion and transfer to a screen. In some cases,camera 207 includes externally powered but internal LEDs to emit light so that the tissue can be seen. In some cases, systems provided herein have optical fibers and an external light source. - A rectangular-shaped
balloon 208, as shown inFIG. 2 , can be coupled to distal end 219 oftubular body 202. InFIG. 2 ,balloon 208 has a proximal end 222 and adistal end 224.Balloon 208 can define aninterior cavity 214 that extends between proximal anddistal ends 222, 224.Balloon 208 can be expanded by fillinginterior cavity 214 with an inflation media, such as saline solution. -
Balloon 208 of ballooncatheter suturing system 200 can be a weeping balloon. Weeping balloon, in the context of the present disclosure, includes a balloon structure defining one or more perforations (also described as apertures or micropores, extending through a balloon wall). As such, weeping balloons can transfer inflation media through a balloon wall, frominterior cavity 214 to exterior surface ofballoon 208. Transferring inflation media to exterior surface can provide a benefit of displacing blood from exterior surface ofballoon 208 that would otherwise blur or obstruct visual imaging throughballoon 208. In other words, inflation media transferred through the one or more perforations can help keep the exterior surface visually clear. If you just put a balloon against an anatomical surface, blood can be trapped on the balloon surface and thus obscures the view, but inflation media (e.g., saline) exiting the pores of a weeping balloon can wash away this blood on the balloon surface adjacent to the wall. In some cases, a weeping balloon used in a balloon catheter suturing system or device provided herein can have at least 3 punctured holes. In some cases, weeping balloons used in balloon catheter suturing systems or devices provided herein can have between 3 and 10,000 punctured holes, between 3 and 1,000 punctured holes, between 3 and 100 punctured holes, or between 3 and 10 punctured holes. In some cases, the number and dimensions of punctured holes in a weeping balloon used in a balloon catheter suturing system or device provided herein allows for an inflation media flow rate of between 1 and 50 ml/minute. In some cases, systems and methods provided herein control an inflation media flow rate to be between 3 ml/minute and 10 ml/minute. In some cases, a weeping balloon used in balloon catheter suturing systems and devices provided herein can have hundreds of holes that perfuse inflation media (e.g., saline) through the balloon and into the blood. In some cases, a weeping balloon used in a balloon catheter suturing system or device provided herein can have a greater pore density in portions of the balloon wall in the center of the field of view and a lower pore density around a periphery of the field of view. -
FIGS. 3A-3J depict another exemplary balloon cathetersuture delivery system 300 having a pair ofpledgets balloon 308.FIG. 3A depicts a distal end ofsystem 300.FIGS. 3B and 3C depict a controlling handle for the system.FIGS. 3D-3I depictsystem 300 being used to suture thevalve annulus 301 of a tricuspid valve. - As shown in
FIG. 3A , ballooncatheter suturing system 300 includes aninner pledget 322 and anouter pledget 324.Inner pledget 322, as shown inFIG. 3E , is held adjacent to a distal end ofballoon 308 by an innerpledget support structure 332, which can extend through a channel formed inballoon 308, andouter pledget 324 is held distal toinner pledget 322 by an outerpledget support structure 334. As shown inFIG.3C , ballooncatheter suturing system 300 can be manipulated by a controllinghandle 390 to position a distal end ofsystem 300 as desired. As shown inFIGS. 3D-3I , the distal end can be manipulated to position tissue 301 (e.g., a valve annuals of the tricuspid valve) betweeninner pledget 322 andouter pledget 324 such thattissue 301 to be sutured there between.FIG. 3D depicts ballooncatheter suturing system 300 after placement, but before suturing.FIG. 3E depictssystem 300 after suturingthreads tissue 301 andinner pledget apertures FIGS. 3F-3H discussed below show how this is accomplished, but do not showballoon 308 in order to more clearly show steps.FIGS. 3I and3J depictpledgets suturing threads needle shuttles -
FIGS. 3D and3F depictinner pledget 322 placed on one side oftissue 301 andouter pledget 324 positioned on an opposite oftissue 301 prior to suturing oftissue 301. As discussed above,balloon 308 is omitted fromFIG. 3F for clarity. AlthoughFIGS. 3A and3D depictinner pledget 322 as being external to balloon 308 with innerpledget support structure 332 and internalpledget support shaft 333 extending through a working channel inballoon 308, some systems provided herein can have a balloon encloseinner pledget 322, internalpledget support structure 332, internalpledget delivery shaft 333, andfastener tool 331.Outer pledget 324, outerpledget support structure 334, outerpledget delivery shaft 335,suturing threads needle shuttles Suturing threads outer pledget apertures catheter suturing system 300 and retained inouter pledget apertures needle shuttles stylet receiving apertures distal anvils stylets fastener tool 331, which are supported onstylets pledget support structure 332,outer pledget support 334, andfastener tool 331 can be moved relative to each other by their respective shafts. Outerpledget support structure 334 is attached to outerpledget delivery shaft 335. As shown inFIGS. 3F ,inner pledget 322 andneedle shuttles tissue 301 to slide there between. -
FIG. 3G depicts the advancement of thefastener tool 331 such thatdistal anvils stylets inner pledget apertures distal anvils stylet receiving apertures needle shuttles distal anvils tissue 301. As shown,fastener tool 331 can be positioned in a working channel formed along or throughballoon 308. In some cases,fastener tool 331 can be positioned withinballoon 308 andstylets balloon 308 prior to passing throughinner pledget apertures balloon 308 is a weeping balloon that is resistant to tear propagation, thus balloon 308 can tolerate the formation of additional apertures formed inballoon 308 due to the passage ofstylets -
FIG. 3H depictssuturing threads tissue 301, and throughinner pledget apertures FIG. 3G ) retractsneedle shuttles suturing threads balloon 308. -
FIG. 3I depictsinner pledget 322 secured againsttissue 301 by suturingthreads Outer pledget 324 is not shown inFIG. 3I , but is on an opposite side oftissue 301.Suturing threads - In some cases,
inner pledget 322 can be positioned withinballoon 308. In cases where aninner pledget 322 is positioned withinballoon 308, as shown inFIG. 3E , innerpledget support structure 332 and innerpledget support shaft 333 can be positioned withinballoon 308. In cases where aninner pledget 322 is positioned withinballoon 308,balloon 308 can be torn or cut to be separated frominner pledget 322 after suturing. In some cases,balloon 308 can be torn or cut to be separated from thepledgets pledgets balloon 308 can rip to be allowinner pledget 322 to be separated from ballooncatheter suturing system 300. - Referring back to
FIGS. 3B and3F , balloon catheter suturing system can include acontrolling handle 390 at a proximal end. Controllinghandle 390 can include ahandle 395, atrigger 391 for controlling thebend 398 of atubular body 382 to control the placement of distal end ofsystem 300.Levers knob 374 can control the advancement and/or retraction of thefastener tool 331, innerpledget support shaft 333, and outerpledget support shaft 335.Levers knob 374 can also control the tying ofsuture threads pledget support shaft 333 is integral withtubular body 382 such that levers 392 and 393 control the movement of thefastener tool 331 and the outerpledget support shaft 335 relative to thetubular body 382 and the innerpledget support shaft 333. In some cases,knob 374 can be used to manipulatefastener tool 331 to tiesuturing threads - Referring to
FIGS. 3A and3D again, a distal end ofsystem 300 can include a plurality ofchannels 380 for delivery of inflation media, tools, fiber optics, cameras, etc. intubular body 382. In some cases, acamera 376 can be integrated into shafttubular body 382. -
FIG. 4 depict another exemplary suture system that can be used with a balloon catheter suture delivery system provided herein. The suture system ofFIG. 4 hasstylet fasteners inner pledget 422 and anouter pledget 424. A balloon catheter suturing system provided herein can have a structure is similar to ballooncatheter suturing system 300 depicted inFIGS. 3A-3I , but uses the suturing system ofFIG. 4 to suture tissue toinner pledget 422 andouter pledget 424. -
Inner pledget 422 can includeinner pledget apertures fasteners Fasteners proximal anvils distal anvils Proximal anvils inner pledget 422 to preventstylet fasteners apertures Distal anvils outer pledget apertures outer pledget 424.Stylet fasteners outer pledget apertures proximal anvils Wires stylet fasteners FIG. 4 depictsinner pledget 422 andstylet fasteners distal anvils outer pledget apertures -
FIG. 4 showsinternal locking structures 428 withinexternal apertures distal anvils stylet fasteners Outer pledget 424 can include aninternal plate 427. In some cases,pledget 424 can be formed by injection molding a polymeric material aroundplate 427.Plate 427 includes two plate apertures surrounded by lockingstructures 428, which can clasp and lockdistal anvils Distal anvils distal anvils structures 428 until a bottom edge of the conical tip passes a lower edge of lockingstructures 428, which results in lockingstructures 428 snapping against a shaft ofstylet fasteners pledgets wires proximal anvils - Balloons used in the balloon catheter suturing systems of
FIGS. 1A-4F can use any suitable balloon shape. As discussed above, in some cases, pledgets are held external to the balloons. In some cases, balloons can include one or more working channels for one or more tools (e.g., pledget support shafts, fastening tool, etc.) to access an anatomical structure (e.g., a tricuspid valve). In some cases, a working channel can have a balloon extend along three sides of the channel. In some cases, a working channel can be surrounded by a donut-shaped balloon. In some cases, balloons used in ballooncatheter suturing systems FIGS. 5A-5F depict exemplary balloon shapes 500, 520, 540, 560, 580, and 590, which can be used in balloon catheter suturing devices and systems provided herein. Although not specifically shown inFIGS. 5A-5D , each of these balloon shapes 500, 520, 540, and 560 can include side working channels and/or through working channels. - Balloons can be constructed from various forms, e.g., a film, sheet or tube of transparent materials. Also, balloons 500, 520, 540, 560, 580, and 590 may be formed into a variety of different shapes.
FIG. 5A shows an example of aballoon 500 having a generally oval shape.FIG. 5B provides an example of aballoon 520 having a proximalspherical portion 522 and a distalspherical portion 524 with anecked portion 526 there between.FIG. 5C provides an example of aballoon 540 having a proximalspherical portion 542 that transitions into a distal flaredportion 544.FIG. 5D shows an example of aballoon 560 having a proximalconical portion 562 coupled to a distalbulbous portion 564.FIG. 5E shows an example of a donut-shapedballoon 580 having a channel or thrulumen 582. Thrulumen 582 can be sized and shaped to allow blood or other medical devices to pass through.FIG. 5F shows an example of a half-flask shapedballoon 590 having aside working channel 592. In some cases, balloons used in balloon catheter suturing devices and systems provided herein have a diameter of between 0.5 cm to 4 cm. In some cases, balloons used in balloon catheter suturing devices and systems provided herein have a diameter of between 1.0 cm to 2 cm. In some cases, balloons used in balloon catheter suturing devices and systems provided herein can provide a field of view of between 0.5 cm to about 3 cm. In some cases, balloons used in balloon catheter suturing devices and systems provided herein can provide a field of view of between 1.0 cm to about 2.0 cm. In some cases, balloons used in balloon catheter suturing devices and systems provided herein can provide a field of view of about 1.5 cm. In some cases, the ratio of longitudinal balloon length versus diameter is approximately 1:1 with the camera's angle of view being about 30 degrees. -
Balloon Balloon tubular body 112 ofFIG. 1 , from a fluid source that connects to a manifold at a proximal end oftubular body 112. In some cases,balloon camera 207 ofFIG. 2 , at a distal end portion of a direct visualization catheter.Balloon balloon balloon -
Balloon balloon balloon -
Balloon balloon balloon balloon balloon 208 or alternative medical devices. -
FIGS. 6A-6D depict an exemplary balloon camera view of aballoon 610 including apledget section 646 in aballoon wall 611 defined by tear off notches in the balloon wall.FIG. 6A depicts theballoon 610 prior to having a fastener 624 (e.g., a staple or a suture) passed through thepledget section 646 and into tissue surrounding the pledgetdetachable section 646.FIG. 6B depicts theballoon 610 having pledgetdetachable section 646 sutured by fastener 624 (e.g., a staple or a suture) to tissue on an exterior surface of the pledgetdetachable section 646.FIG. 6C shows theballoon 610 having ahole 658 from where the pledgetdetachable section 646 was removed, andFIG. 6D depicts the suturedpledget 656. -
FIGS. 7A-7C illustrate a camera view showing howdetachable sections 746 can be sutured to an anatomical location and separated fromballoon 710.FIGS. 8A-8C depict a view of this procedure from a position distal to the balloon. As shown inFIGS. 7A and8A , aballoon 710 can include pledgetdetachable sections 746 and a through workingchannel 722, through which a suturing thread rides with a fastening tool (not shown). The fasteningtool working channel 722 can be a central hole or pore inballoon 710. As shown inFIG. 7A , each pledgetdetachable section 746 includestear notches 747. As shown inFIGS. 7B, 7C ,8B and 8C , asuture thread 712 can be passed into workingchannel 722 by a fastening tool (not shown), piercing tissue outside ofballoon 710 and piercing pledgetdetachable section 746 of the wall of balloon. In some cases, as shown inFIGS. 7C and8C , after an initial suture is made,balloon 710 can be moved or retracted to separate the suturedpledget 756 from theballoon 710. In some cases, multiple pledgetdetachable sections 746 are sutured to different anatomical locations prior to separating the pledgetdetachable sections 746 fromballoon 710 to product suturedpledgets 756. In some cases, the pledgetdetachable sections 746 are laminated to an outer surface of the balloon wall such that removal ofpledget 756 does not produce a pledget sized hole inballoon 710. In some cases, pledgetdetachable sections 746 are defined by a weakened score line to produce a tear line around pledgetdetachable sections 746. -
FIGS. 9A-9C show cross-sectional views of various examples oftubular bodies FIG. 9A ,tubular body 900 includes a plurality of lumens that includes acentral lumen 902 and a plurality of non-central, surrounding lumens 904. Plurality of non-central, surrounding lumens 904 ofFIG. 9A includes four circular surrounding lumens 906 and one rectangular surrounding lumen 908. Central lumen and surrounding lumens can be formed of various sizes and shapes. For example, as shown inFIGS. 9A ,central lumen 902 can be larger than some or all non-central, surrounding lumens 904. In some cases, as shown, some of the non-central, surrounding lumens 904 can be larger than other surrounding lumens. In some cases,tubular body 900 may have only non-central, surrounding lumens 904, i.e., no central lumen. In some cases, tubular body may have one lumen or multiple lumen, for example, up to 15 lumens. - In
FIG. 9B ,tubular body 920 includes a plurality of lumens that includes acentral lumen 922 and plurality of non-central, surrounding lumens 924. Plurality of non-central, surrounding lumens 924 ofFIG. 9B includes three circular surrounding lumens 926, one rectangular surrounding lumen 928, and six slot-shaped lumens 930. - In
FIG. 9C ,tubular body 940 includes a plurality of lumens that includes acentral lumen 942 and plurality of non-central, surrounding lumens 944. Plurality of surrounding lumens 944 ofFIG. 9C includes three circular surrounding lumens 946, one rectangular surrounding lumen 948, and six curvilinear, slot-shaped lumens 950. - Balloon catheter suturing devices and systems provided herein may include a balloon constructed of one or more polymeric, transparent materials. In some cases, at least a portion of the balloon can be constructed of a polymeric fibrous matrix or a polymer film. In various cases, the balloon is constructed of a modified thermoset polymer (also described as a composite of polymeric fibers and polymers).
-
FIG. 10 shows a cross-sectional view of a balloon material that includes a modifiedthermoset polymer 1000. As shown,polymer 1000 includes an inner layer 1002 (which may also be referred to as a first layer) and an outer layer 1004 (which may also be referred to as a second layer). Inner andouter layers FIG. 10 each includes one or more polymeric materials. In particular,inner layer 1002 ofFIG. 10 includes athermoset polymer 1008 and a plurality of polymeric fibers 1010 (represented by crosshatch lines in the figure) embedded withinthermoset polymer 1008. As shown inFIG. 10 ,thermoset polymer 1008 is embedded with individual fibers that make up the plurality ofpolymeric fibers 1010. In some cases,polymer 1008 can fully or partially fill space between some of the individual fibers. Described differently,thermoset polymer 1008 can interpenetrate the space between individual fibers that make up the plurality ofpolymeric fibers 1010. In some cases,thermoset polymer 1008 can covalently bond to the individual fibers. In some cases,polymer 1008 can mechanically engages with the individual fibers by interlocking with at least a portion of the plurality of polymeric fibers 1010.Exemplary materials ofvarious thermoset polymers 1008 include, but are not limited to, polyurethanes, silicones, phenolic polymers, amino polymers, epoxy polymers and combinations thereof.FIGS. 11B-11D depict cross-sectional views of an exemplary composite that includes polymeric fibers embedded within a silicone thermoset polymer. - Suitable silicones may include, but are not limited to, polydimethylsiloxane (PDMS), polydiphenylsiloxane, polymethylphenylsiloxane, fluorosilicones such as poly methyl(3,3,3-trifluoropropyl)siloxane and combinations thereof. The plurality of
polymeric fibers 1010 ofFIG. 10 can be randomly oriented. In such cases, the plurality ofpolymeric fibers 1010 may form a nonwoven fibrous matrix. In some cases, the plurality ofpolymeric fibers 1010 can be oriented in a regular pattern. The plurality ofpolymeric fibers 1010 oriented in a regular pattern may form a woven fibrous matrix. The nonwoven fibrous matrix can provide the benefit of providing multiaxial strength to a material while the woven fibrous matrix can provide uniaxial strength directed to a particular axis. - Polymeric fibers can be constructed of biocompatible materials including various thermoplastic materials. In particular, fibers may be formed of thermoplastic materials suitable for electrospinning, force spinning or melt-blowing processes. Electrospinning is a process that uses electrical charge to create fibers from a liquid while force spinning is a process that uses centrifugal force to create fibers. Melt-blowing is a process in which a molten thermoplastic resin is extruded through a die and then stretched and cooled with high-velocity air to form long, fine fibers. In some cases, fibers can be constructed of various polymers that exhibit hydrophilic or hydrophobic characteristics. In some cases, fibers can be raw e-spun fibers, such as those shown in
FIG. 11A . - Suitable polymers for fibers can be formed from fluoropolymers including, but not limited to, for example, polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF) (e.g. Kynar™ and Solef™), poly(vinylidene fluoride-co-hexafluoropropene) (PVDF-HFP), cyclic fluoropolyethers such as Cytop™, perfluoroalkoxy alkane resins (PFA), poly(pentafluorostyrene), poly(2,2,3,3,4,4,4-heptafluorobutyl methacrylate), fluoroethylene-alkyl vinyl ether (FEVE; Lumiflon(TM)), poly[4,5 difluoro 2,2 bis(trifluoromethyl)-1,3-dioxole-co-tetrafluoroethylene, and combinations thereof. Other suitable polymers for forming fibers are urethane-based polymers that include, but are not limited to, for example, polyurethanes, polyurethane elastomers (e.g. Pellethane), polyether-based polyurethanes (e.g. Tecothane), polycarbonate-based polyurethanes (e.g. Bionate and/or Chronoflex) and combinations thereof. Other examples of suitable polymer materials for fibers can include, but are not limited to, polycarbonate, polyether, polyester, polyamide, nylon 6, nylon 12,, nylon 66,
nylon 10, nylon 11, polyetherimide and combinations thereof. In some embodiments, fibers are formed from block polymers such as, for example, a poly(styrene-b-isobutylene-b-styrene) (SIBS) tri-block polymer and/or a polyisobutylene polyurethane (PIB-PUR). - Polymeric fibers can have diameters in the range of about 40 nanometers (nm) to 10,000 nm, for example. The fiber diameter size can include a range of about 100 nm to 3,000 nm. In some examples, suitable fiber diameter sizes can include ranges of about 40 nm to 2,000 nm, about 100 nm to 1,500 nm or about 100 nm to 1,000 nm, for example. In still further examples, fibers 412 can have average fiber diameters ranging between about 900 nm to 10,000 nanometers or between about 800 nm to 10,000. In some cases, fibers 912 are nanofibers having diameters less than 1,000 nm. For example, nanofiber diameters can range from about 100 nm to 800 nm, or be any value there between. In some examples, nanofiber diameters can range from 100 nm to 400 nm.
-
Outer layer 1004 ofFIG. 10 can include one or more hydrogels (also described as crosslinkable, hydrophilizing agents). Hydrogels are a network of hydrophilic polymer chains that are bonded together by association bonds, such as hydrogen bonds and intermolecular hydrophobic associations. Hydrogels have structures that are capable of retaining large amounts of water. In various cases,outer layer 1004 includes hydrogels that are optically transparent in vivo, i.e., when placed into a body. In some cases,outer layer 1004 includes hydrogels having anti-fouling properties, for example, are resistant to protein binding and platelet adsorption. In some cases, hydrogels are anti-thrombogenic. Material having anti-fouling properties provide the advantage of being optically transparent for longer durations in vivo. Anti-thromobogenic materials provide implantable components and devices with a benefit of long-term biocompatibility in vivo. - Various suitable hydrogels include, but are not limited to, olefin based polymers such as a polyethylene glycol (PEG) or a PEG derivative, for example, PEG-dimethacrylate, UV-curable PEG, PEG diacrylate, polyethylene glycol-neopentyl glycol diacrylate methyl acrylate (PEG-NPDGA), PEG-BioslideTM, PEG-Z-GlideTM, chitosan-PEG, thiol-PEG, maleimide-PEG, amino-PEG, azide-PEG, and carboxyl-PEG. Examples of other suitable hydrogels include, but are not limited to, polyvinylpyrrolidone (PVP), polyvinyl acetate (PVA), glycosaminoglycans (e.g. heparin), poly [N-(2-hydroxypropyl) methacrylamide] (PHPMA), poly(vinyl pyrrolidone), polyethylene/oligoethylene, polyHEMA, polytetraglyme, hyaluronic acid, chitosan and any derivatives thereof.
- In some cases, at least a portion of the hydrogel is embedded with a plurality of
polymeric fibers 1010. In some cases, the hydrogel can covalently bond to individual fibers that make up the plurality ofpolymeric fibers 1010. In some cases, the hydrogel can bond to individual fibers by chemical association bonding, such as hydrogen bonding and/or intermolecular hydrophobic associations. In some cases, the hydrogel can mechanically engage with at least a portion of the plurality ofpolymeric fibers 1010 by interpenetrating space between individual fibers protruding from a surface of an adjacent layer. For example, as shown inFIG. 10 , the plurality ofpolymer fibers 1010 is partially embedded in aportion 1012 ofouter layer 1004 located adjacent theinner layer 1002. In some cases, the hydrogel can also be incorporated with a polymer solution from which spun fibers are formed. As a result, hydrophilic polymer chains can be intertwined or entangled with another polymer. - In some cases, selection portions of the different layers shown in
FIGS. 10 and/or 11B-11D can be treated to create weakened portions of the balloon to create tear lines for separating a pledget section of a balloon wall. In some cases, the polymeric fiber layers can have be cut along desired tear lines prior to combining the fibers with the thermoset polymer. -
FIG. 12A is a flowchart of anexample method 1200 of manufacturing balloons provided herein, such asballoon operations subsequent operations 1214 forms an outer layer of balloon. Atoperation 1211, a plurality of polymeric nanofibers (or, alternatively, a plurality of polymeric fibers) are formed into an interior cavity of a balloon mold using an electrospinning process. In some cases, the electrospinning process can leave sections uncovered to produce weakened sections. Alternatively, a plurality of polymeric nanofibers can be preformed into a thin, nonwoven fibrous matrix film or sheet. In some cases, a thin, nonwoven fibrous matrix film or sheet can have score lines cut into to produce weakened tear lines. Once preformed, nonwoven fibrous matrix film or sheet can be rolled and placed into the interior cavity of the balloon mold. In some cases, nanofibers may be constructed using processes other than the electrospinning process, for example, a force spinning process. - At
operation 1212, a curable thermoset material, e.g. polydimethylsiloxane (PDMS), in liquid form is injected into the mold. Thermoset material at least partially penetrates the plurality of nanofibers. - At
operation 1213, thermoset material is cured to form a pre-formed balloon. - At
operation 1214, pre-formed balloon is removed from balloon mold and an exterior surface of the pre-formed balloon is treated with a crosslinkable, hydrophilizing agent, such as PEG-dimethacrylate, described herein. Following the treatment, the hydrophilized balloon may continue on to other manufacturing operations to build a direct visualization catheter or an alternative medical device. -
FIG. 12B is a flowchart of anotherexample method 1200 of manufacturing balloons provided herein, such asballoon operations operation 1260 forms an outer layer of balloon. Atoperation 1210, thermoset material is injected into a balloon mold using a curable thermoset material and only partially cured. - At
operation 1220, a plurality of polymeric nanofibers are formed onto partially cured thermoset material using an electrospinning process or alternative process, such as force spinning. Because thermoset material is not fully cured, at least a portion of plurality of polymeric nanofibers penetrates into thermoset material such that nanofibers are exposed at an exterior surface of balloon. In some cases, the electrospinning process and/or the force spinning process can arrange the delivery of fibers to create weakened tear lines in a resulting balloon. - At
operation 1230, thermoset material is cured to form an inner layer of a pre-formed balloon. Thermoset material may be cured as described herein. - At
operation 1240, pre-formed balloon is optionally removed from balloon mold and, atoperation 1250, per-formed balloon is inverted such that at least a portion of plurality of polymeric nanofibers are exposed along an exterior surface of balloon. In some cases,operation step 1250 may not be necessary if during operation, at least a portion of the plurality of polymeric nanofibers penetrates into thermoset material such that fibers would be exposed at exterior surface of a non-inverted balloon - At
operation 1260, exterior surface of the pre-formed balloon is treated with a crosslinkable, hydrophilizing agent, e.g., PEG-dimethacrylate, described herein. Following the treatment, a hydrophilized balloon may continue on to other manufacturing operations, if applicable. -
FIG. 13 is a flowchart of anotherexample method 1300 of manufacturing balloons provided herein, such asballoon operations subsequent operation 1340 forms an outer layer of balloon. Atoperation 1310, a curable thermoset material, e.g. polydimethylsiloxane (PDMS), is extruded or overmolded onto a shaped mandrel. The mandrel can be formed in various balloon shapes or tubular shapes. - At
operation 1320, a plurality of polymeric nanofibers are formed on a shaped mandrel using an electrospinning process or a force spinning process. The plurality of polymeric nanofibers are formed onto thermoset material such that at portion of the nanofibers penetrates into thermoset material and another portion of the nanofibers remains exposed at an exterior surface of the balloon. In some cases, the electrospinning process and/or the force spinning process can arrange the delivery of fibers to create weakened tear lines in a resulting balloon. - At
operation 1330, thermoset material is fully cured to form an inner layer of a pre-formed balloon. Thermoset material may be cured as described herein. - At
operation 1340, the pre-formed balloon is treated with a crosslinkable, hydrophilizing agent, such as PEG-dimethacrylate, described herein. A hydrophilized balloon may be removed from the mandrel at any time after thermoset material has been cured. Hydrophilized balloon may be subject to subsequent manufacturing operations to build a direct visualization catheter or an alternative medical device. -
FIG. 14 is a flowchart of amethod 1400 for securing a pledget and fastener to a target area, e.g., a left atrium of a heart, during a surgical procedure using a balloon catheter suturing system in accordance with some of the embodiments provided herein. Atoperation 1410, a target area within a patient can be located and initially inspected by advancing at least a portion of the balloon catheter suturing system to the target area. In some cases, balloon catheter suturing system or portions thereof, e.g., a visualization portion, is advanced to the target area to provide visual or ultrasound images of the target area. In some cases, the balloon catheter suturing system or portions thereof, e.g., a visualization portion, can be advanced to the target area over a guidewire or within a guide catheter. Once at the target area, the balloon catheter suturing system or portions thereof can provide direct visual images or ultrasound images for the inspection. In some cases, inspection can also include injecting contrast media into the targeted area and viewing the area using fluoroscopic equipment. - At
operation 1420, the balloon catheter suturing system, is advanced to the target area and a portion thereof expanded at the target area to stabilize the balloon catheter suturing system. In some cases, a balloon or stent is expanded to stabilize the balloon catheter suturing system. - At
operation 1430, a desired surgical location at the target area can be verified by using direct visual or ultrasound imaging provided by the balloon catheter suturing system. In some cases, a primary camera located in balloon or stent portion of catheter can be used to verify the surgical location. In some cases, the balloon catheter suturing system includes a secondary visualization portion that can be used in conjunction with the primary camera to visually verify the surgical location. In such cases, primary camera may provide anterior visual images and the secondary visualization portion may provide posterior visual images. - At
operation 1440, the balloon catheter suturing system can be manipulated such that a pledget or pledget section of a balloon is positioned near or at the desired surgical location. In some cases, a distal end portion of direct visualization catheter can be deflected at a specific angle to position one or more pledgets in a desired location. In some cases, a select portion of direct visual catheter is advanced to the desired location. - At
operation 1450, the tissue is pierced using a fastening tool. In some cases, a portion of the balloon catheter suturing system, e.g., a needle, can be used to pierce tissue at the surgical location. In some cases, the balloon catheter suturing system can advance a fastener, such as a staple or clasp, such that the fastener pierces the tissue at the surgical location and a pledget section of a balloon. In some cases, the advancement of the fastener can interlock the fastener with a pledget. - At
operation 1460, fastener is attached to tissue and the pledget or pledget section of a balloon. In some cases, attaching the fastener to tissue can include securing a suture through tissue at the surgical location and through a hole in a pledget. In some cases, attaching fastener to tissue can include attaching a pledget, staple or clasp to tissue at the surgical location through a pledget section of a balloon wall. - At
operation 1470, the fastener and pledget are released from the balloon catheter suturing system. In some cases, a pledget section of a balloon wall is torn away from the balloon by retracting the balloon. In some cases, the pledget is released from the catheter using an actuator at a proximal end of the balloon catheter suturing system. In some cases, fastener is released from the catheter using an actuator at a proximal end of the balloon catheter suturing system. In some cases, pledget and/or fastener is released from the catheter by advancing a portion of the catheter, e.g., a pusher rod, to push the fastener away from a distal end of the catheter. In some cases, pledgets and/or fastener, such as a suture thread, may not be released from the catheter until multiple surgical areas have been secured with the fasteners and pledgets. -
FIG. 15 shows anexemplary fastening tool 1500, which can be used in balloon catheter suturing systems provided herein.Fastening tool 1500 includes a tubularmain body 1502 with adistal end portion 1504, aproximal end portion 1506, and a lumen (not shown) therethrough that is sized to receive afastener 1508. As shown, tubularmain body 1502 can be generally straight. In some cases, a portion of tubularmain body 1502, e.g., adistal end portion 1504, can be pre-formed to bend at a suitable angle or have a curvature that allowsfastening tool 1500 to better access target tissue areas during a surgical procedure. In some cases, tubularmain body 1502 can be deflectable such that thedistal end portion 1504 can deflect to different angles during the procedure. -
Distal end portion 1504 offastening tool 1500 includes adistal end 1514 and defines adistal opening 1516 adapted to receive and temporarily retainfastener 1508. As shown inFIG. 15 , in some cases, opening 1516 is adapted to retain a ring-shapedfastener 1508.Fastening tool 1500 can be coupleable to various types offasteners 1508, for example, suture, a suture with a pledget, clips, and/or staples.Fastening tool 1500 can be used to deliver and affixfastener 1508 to tissue, e.g., annulus of a heart valve. -
Proximal end portion 1506 can include aproximal end 1518 and defines aproximal opening 1520 adapted to receivefastener 1508. InFIG. 15 ,proximal end portion 1506 has asleeve 1522 adapted to receive at least one rod, e.g., apush rod 1524 and/or aninsertion rod 1526.Insertion rod 1526 can be used to loadfastener 1508 intosleeve 1522.Push rod 1524 can be used to advancefastener 1508 throughsleeve 1522 into tubularmain body 1502.Push rod 1524 can be sized and shaped to be received through a lumen (not shown) of tubularmain body 1502 and be extended fromdistal opening 1516. In some cases, a single rod can be used as bothpush rod 1524 andinsertion rod 1526. -
FIGS. 16A-16C show cross-sectional views of anexemplary fastening tool 1600, which can be used in balloon catheter suturing systems provided herein, at adistal end portion 1602.Fastening tool 1600 can include atubular body 1604 defining alumen 1606 adapted to receive afastener 1608, e.g., an annulus clasp, and adistal end 1610 defining adistal opening 1612. As shown inFIGS. 16A-16C ,fastener 1608 can be advanced throughdistal end portion 1602 offastening tool 1600 and released fromfastening tool 1600 atdistal opening 1612.Lumen 1606 can be sized and shaped to receivefastener 1608. Lumen can also be sized and shaped to receive at least a portion of apush rod 1614.Push rod 1614 can be used to about aproximal end 1616 offastener 1608 and be translated distally to pushfastener 1608 todistal end 1610 offastening tool 1600.Distal opening 1612 can be adapted to allowfastener 1608 to pass through. As shown, in some cases,distal end 1610 can include asensor 1618 that indicates whenfastener 1608 has reacheddistal opening 1612.Sensor 1618 can provide location information offastener 1608 to indicate whenfastener 1608 is ready to be released fromfastening tool 1600.Sensor 1618 may also be used to prevent accidental release of fastener 808. - In
FIG. 16A ,push rod 1614 andfastener 1608 are located atdistal end portion 1602 offastening tool 1600 proximate todistal opening 1612. InFIG. 16B ,push rod 1614 andfastener 1608 are distally translated such thatdistal end 1620 offastener 1608 begins to emerge fromdistal opening 1612. In some cases, as shown,distal end 1620 offastener 1608 can begin to form into a preformed shape, e.g., begin to curl into a ring-like clasp. InFIG.16C ,push rod 1614 is further distally translated such thatfastener 1608 extends fromdistal opening 1612 in a partially deployed state. As shown inFIG. 16C ,fastener 1608 can curl into a semi-circular shape in partially deployed state.Fastener 1608 can be fully deployed to form a full ring by further distally translatingpush rod 1614 such that fastener extends completely fromdistal opening 1612.Fastener 1608 can be transitioned from the partially deployed state to the fully deployed after the device has been properly positioned at a target surgical location.Fastener 1608 can be fastened to tissue when transitioned from the partially deployed state to the fully deployed state. In some cases,sensor 1618 can be used to identify thatfastener 1608 is ready to be fully deployed prior to being released fromfastening tool 1600. -
Figures 17A-17G show variousexemplary fasteners - As shown in
FIGS. 17A and 17B ,fastener single body sharp tips FIG. 17A ,body 1702 offastener 1700 can define at least one thru-hole 1706. In some cases, thru-hole can be sized to receive a suture (not shown). Asingle body fastener sharp tips FIGS. 17C and 17D ,fastener hinge connector tissue penetrating tips -
FIGS. 17E-17G show anotherexemplary fastener 1740 that can be formed of asingle body 1742 that can be shaped into multiple configurations.Fastener 1740 can be shaped in a first configuration (seeFIG. 17E ) prior to implantation and a second configuration (seeFIG. 17F and 17G ) during and after implantation. In some cases,fastener 1740 can be made of a shape memory material or a malleable material.Fastener 1740 can be made of various shape memory metals or polymers and be pre-formed into a desired final shape. In some cases,fastener 1740 can be fixed into second configuration by a connector, such as aclip 1741, as shown inFIG. 17G . - As shown in
FIG. 17E , fastener can be shaped as a flat segment 1744 in first configuration when being delivered by a direct visualization catheter (or a direct visualization system) to a surgical site. Fastener can form into the desired final shape, e.g., a ring-like clasp 1746 as shown inFIGS. 17F and 17G , in second configuration when implanted into a patient. - A number of embodiments of the direct visualization devices, systems, and methods have been described. Nevertheless, it will be understood that various modifications may be made without departing from the scope of the subject matter described herein. Accordingly, other embodiments are within the scope of the following claims.
Claims (14)
- A balloon catheter suturing system (100; 200; 300) comprising:an elongate shaft (112) defining a lumen and having a distal end portion (118) and a proximal end portion (114);a balloon (108; 208; 308; 500; 520; 540; 560; 580; 590; 610; 710) attached to the distal end portion, the balloon having a transparent wall;at least a first pledget (126; 206; 322; 324; 422; 424; 646; 756) secured to the balloon by a portion of the balloon catheter suturing system adjacent the balloon; andat least one fastener (212; 412a; 412b; 624; 1508; 1608; 1700; 1710; 1720; 1730; 1740) adapted to fasten the first pledget to an anatomic structure when the balloon catheter suturing system is positioned within a patient, characterised in that the balloon is a weeping balloon.
- The balloon catheter suturing system (100; 200; 300) of claim 1, wherein the first pledget is part of the transparent wall.
- The balloon catheter suturing system (100; 200; 300) of claim 1, wherein the first pledget is held by an internal pledget support structure (333) within the transparent wall of the balloon.
- The balloon catheter suturing system (100; 200; 300) of claim 1, wherein the first pledget is held by a first pledget support structure outside the transparent wall of the balloon distal to the balloon.
- The balloon catheter suturing system (100; 200; 300) of claim 4, further comprising a second pledget (322; 324) held by a second pledget support structure (332; 334) proximal to the first pledget (322; 324), wherein at least one fastener (312a; 312b) is adapted to fasten the first and second pledgets (322, 324) together on opposite sides of the anatomic structure.
- The balloon catheter suturing system (100; 200; 300) of claim 5, wherein the second pledget is positioned within the transparent wall of the balloon.
- The balloon catheter suturing system (100; 200; 300) of claim 5, wherein the second pledget is positioned outside of the transparent wall.
- The balloon catheter suturing system (100; 200; 300) of claim 2, wherein the first pledget is defined by weakened sections defining one or more tear lines around the first pledget in the transparent wall.
- The balloon catheter suturing system (100; 200; 300) of claim 2, wherein the first pledget is adapted to delaminate from a portion of the transparent wall.
- The balloon catheter suturing system (100; 200; 300) of claim 1, wherein the transparent wall comprises at least a first layer (1002) comprising a thermoset polymer and a plurality of polymeric fibers at least partially embedded in the thermoset polymer.
- The balloon catheter suturing system (100; 200; 300) of claim 10, wherein the transparent wall comprises at least a second layer (1004) disposed on the first layer, wherein the second layer comprises a hydrogel.
- The balloon catheter suturing system of claim 10 or claim 11, wherein the polymeric fibers are electrospun fibers randomly oriented within the thermoset polymer.
- The balloon catheter suturing system of one of claims 10-12, wherein the thermoset polymer comprise a silicone, such as polydimethylsiloxane (PDMS).
- The balloon catheter suturing system (100; 200; 300) of one of the preceding claims, wherein the balloon defines a working channel there through.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20190762.3A EP3769807B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter suturing systems having pledgets |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562106936P | 2015-01-23 | 2015-01-23 | |
US201562107068P | 2015-01-23 | 2015-01-23 | |
PCT/US2016/014546 WO2016118875A1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter suturing systems, methods, and devices having pledgets |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20190762.3A Division EP3769807B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter suturing systems having pledgets |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3247445A1 EP3247445A1 (en) | 2017-11-29 |
EP3247445B1 true EP3247445B1 (en) | 2020-08-19 |
Family
ID=55404773
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16708482.1A Active EP3247445B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter suturing systems and devices having pledgets |
EP16708759.2A Active EP3247446B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter visualization systems |
EP20191047.8A Active EP3777952B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter visualization systems |
EP20190762.3A Active EP3769807B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter suturing systems having pledgets |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16708759.2A Active EP3247446B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter visualization systems |
EP20191047.8A Active EP3777952B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter visualization systems |
EP20190762.3A Active EP3769807B1 (en) | 2015-01-23 | 2016-01-22 | Balloon catheter suturing systems having pledgets |
Country Status (6)
Country | Link |
---|---|
US (4) | US20160213237A1 (en) |
EP (4) | EP3247445B1 (en) |
JP (3) | JP6816002B2 (en) |
CN (2) | CN107529942B (en) |
CA (2) | CA2974142C (en) |
WO (2) | WO2016118875A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10736624B2 (en) | 2014-05-19 | 2020-08-11 | Lsi Solutions, Inc | Minimally invasive surgical suturing device for papillary muscles and methods thereof |
JP6816002B2 (en) * | 2015-01-23 | 2021-01-20 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Balloon catheter visualization system, method, and device with pledge |
EP3297540B1 (en) * | 2015-05-19 | 2020-11-04 | LSI Solutions, Inc. | Minimally invasive surgical suturing device for papillary muscles |
US11350838B2 (en) * | 2016-03-11 | 2022-06-07 | Laborie Medical Technologies Corp. | Pressure catheter device |
CA3016703A1 (en) | 2016-03-11 | 2017-09-14 | Laborie Medical Technologies Corp. | Pressure catheter and connector device |
JP6726762B2 (en) | 2016-04-19 | 2020-07-22 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Exudation balloon device |
US10898181B2 (en) | 2017-03-17 | 2021-01-26 | Cypris Medical, Inc. | Suturing system |
WO2019036548A2 (en) * | 2017-08-17 | 2019-02-21 | Boston Scientific Scimed, Inc. | Anchor delivery system and methods for valve repair |
EP3716868B8 (en) * | 2017-11-30 | 2024-02-14 | Boston Scientific Scimed, Inc. | Delivery and occlusion devices for paravalvular leak |
US10660637B2 (en) | 2018-04-06 | 2020-05-26 | Cypris Medical, Inc. | Suturing system |
US11033261B2 (en) * | 2018-05-31 | 2021-06-15 | Cypris Medical, Inc. | Suture system |
USD880690S1 (en) | 2018-07-26 | 2020-04-07 | Laborie Medical Technologies Corp. | Pressure catheter connector |
US10893834B2 (en) | 2018-07-26 | 2021-01-19 | Laborie Medical Technologies Corp. | Charger for pressure sensing catheter |
US10531834B1 (en) | 2018-07-26 | 2020-01-14 | Laborie Medical Technologies Corp. | Pressure catheter connector |
US11219383B2 (en) | 2019-01-28 | 2022-01-11 | Laborie Medical Technologies Corp. | Radiofrequency detection and identification of pressure sensing catheters |
EP3848083A1 (en) * | 2019-09-27 | 2021-07-14 | Cook Medical Technologies LLC | Method of manufacturing a silicone medical balloon |
US11260146B2 (en) * | 2019-11-27 | 2022-03-01 | Terumo Medical Corporation | Seal-healing valve for a medical instrument |
CN114081675B (en) * | 2021-09-28 | 2023-11-21 | 四川大学华西医院 | transcatheter aortic valve replacement assist device |
Family Cites Families (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4961738A (en) * | 1987-01-28 | 1990-10-09 | Mackin Robert A | Angioplasty catheter with illumination and visualization within angioplasty balloon |
US4784133A (en) | 1987-01-28 | 1988-11-15 | Mackin Robert A | Working well balloon angioscope and method |
US5087244A (en) * | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
JP2510428B2 (en) | 1991-01-31 | 1996-06-26 | 修太郎 佐竹 | Balloon catheter |
WO1992021292A2 (en) | 1991-05-29 | 1992-12-10 | Origin Medsystems, Inc. | Retraction apparatus and methods for endoscopic surgery |
US5254089A (en) | 1992-04-02 | 1993-10-19 | Boston Scientific Corp. | Medication dispensing balloon catheter |
US5330490A (en) * | 1992-04-10 | 1994-07-19 | Wilk Peter J | Endoscopic device, prosthesis and method for use in endovascular repair |
US5400773A (en) | 1993-01-19 | 1995-03-28 | Loma Linda University Medical Center | Inflatable endoscopic retractor |
US6161543A (en) | 1993-02-22 | 2000-12-19 | Epicor, Inc. | Methods of epicardial ablation for creating a lesion around the pulmonary veins |
US5797960A (en) * | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
ATE261744T1 (en) | 1994-01-06 | 2004-04-15 | Scimed Life Systems Inc | BALLOON CATHETER WITH THERMOPLASTIC POLYIMIDE BALLOON |
US5569183A (en) | 1994-06-01 | 1996-10-29 | Archimedes Surgical, Inc. | Method for performing surgery around a viewing space in the interior of the body |
US5509899A (en) * | 1994-09-22 | 1996-04-23 | Boston Scientific Corp. | Medical device with lubricious coating |
US5876426A (en) | 1996-06-13 | 1999-03-02 | Scimed Life Systems, Inc. | System and method of providing a blood-free interface for intravascular light delivery |
US5709653A (en) | 1996-07-25 | 1998-01-20 | Cordis Corporation | Photodynamic therapy balloon catheter with microporous membrane |
GB9616267D0 (en) | 1996-08-02 | 1996-09-11 | Ranier Ltd | Balloon catheter |
JP3153771B2 (en) | 1996-08-05 | 2001-04-09 | シャープ株式会社 | Optical waveguide type reduced image sensor and method of manufacturing the same |
US5833682A (en) | 1996-08-26 | 1998-11-10 | Illumenex Corporation | Light delivery system with blood flushing capability |
US5964751A (en) | 1996-08-26 | 1999-10-12 | Illumenex Corporation | Light delivery system with blood flushing capability |
US5902299A (en) | 1997-07-29 | 1999-05-11 | Jayaraman; Swaminathan | Cryotherapy method for reducing tissue injury after balloon angioplasty or stent implantation |
US6517566B1 (en) | 1998-05-11 | 2003-02-11 | Surgical Connections, Inc. | Devices and methods for treating e.g. urinary stress incontinence |
US7947015B2 (en) | 1999-01-25 | 2011-05-24 | Atrium Medical Corporation | Application of a therapeutic substance to a tissue location using an expandable medical device |
US20040215233A1 (en) | 2000-06-16 | 2004-10-28 | Magenta Medical Corporation | Methods and apparatus for forming anastomotic sites |
US7033373B2 (en) * | 2000-11-03 | 2006-04-25 | Satiety, Inc. | Method and device for use in minimally invasive placement of space-occupying intragastric devices |
US6444324B1 (en) * | 2000-12-01 | 2002-09-03 | Scimed Life Systems, Inc. | Lubricated catheter balloon |
US6697677B2 (en) | 2000-12-28 | 2004-02-24 | Medtronic, Inc. | System and method for placing a medical electrical lead |
US6544223B1 (en) | 2001-01-05 | 2003-04-08 | Advanced Cardiovascular Systems, Inc. | Balloon catheter for delivering therapeutic agents |
US6808518B2 (en) | 2001-09-28 | 2004-10-26 | Ethicon, Inc. | Methods and devices for treating diseased blood vessels |
US6978176B2 (en) * | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
US20080249504A1 (en) * | 2007-04-06 | 2008-10-09 | Lattouf Omar M | Instrument port |
WO2003105670A2 (en) | 2002-01-10 | 2003-12-24 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
JP3331215B1 (en) * | 2002-02-04 | 2002-10-07 | 治郎 蟹江 | Biological suture |
US7976564B2 (en) * | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
EP1870018A3 (en) | 2002-05-30 | 2008-08-06 | The Board of Trustees of The Leland Stanford Junior University | Apparatus and methods for coronary sinus access |
EP1526888A2 (en) | 2002-08-05 | 2005-05-04 | Miravant Medical Technologies | Light delivery catheter |
JP4351832B2 (en) | 2002-08-05 | 2009-10-28 | テルモ株式会社 | Balloon catheter |
US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
US20040127932A1 (en) * | 2002-09-12 | 2004-07-01 | Shah Tilak M. | Dip-molded polymeric medical devices with reverse thickness gradient, and method of making same |
EP1585572A4 (en) * | 2002-09-20 | 2010-02-24 | Flowmedica Inc | Method and apparatus for intra aortic substance delivery to a branch vessel |
US7048714B2 (en) | 2002-10-30 | 2006-05-23 | Biorest Ltd. | Drug eluting medical device with an expandable portion for drug release |
JP2005013708A (en) | 2003-05-30 | 2005-01-20 | Olympus Corp | Endoscope and method for assembling it |
AU2003253773A1 (en) * | 2003-06-30 | 2005-02-14 | Magenta Medical Corporation | Methods and apparatus for forming anastomotic sites |
US7534204B2 (en) * | 2003-09-03 | 2009-05-19 | Guided Delivery Systems, Inc. | Cardiac visualization devices and methods |
JP2005081202A (en) | 2003-09-05 | 2005-03-31 | Nakabayashi Co Ltd | Waste crushing vehicle |
US8172747B2 (en) | 2003-09-25 | 2012-05-08 | Hansen Medical, Inc. | Balloon visualization for traversing a tissue wall |
US7478390B2 (en) | 2003-09-25 | 2009-01-13 | International Business Machines Corporation | Task queue management of virtual devices using a plurality of processors |
US20050247320A1 (en) * | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US20050080313A1 (en) | 2003-10-10 | 2005-04-14 | Stewart Daren L. | Applicator for radiation treatment of a cavity |
JP4496223B2 (en) | 2003-11-06 | 2010-07-07 | エヌエムティー メディカル, インコーポレイティッド | Septal penetration device |
US20050228452A1 (en) | 2004-02-11 | 2005-10-13 | Mourlas Nicholas J | Steerable catheters and methods for using them |
US20070233170A1 (en) * | 2004-03-23 | 2007-10-04 | Michael Gertner | Extragastric Balloon |
US8343031B2 (en) * | 2004-03-23 | 2013-01-01 | Michael Gertner | Obesity treatment systems |
US7803150B2 (en) | 2004-04-21 | 2010-09-28 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US20060004323A1 (en) | 2004-04-21 | 2006-01-05 | Exploramed Nc1, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US8764729B2 (en) | 2004-04-21 | 2014-07-01 | Acclarent, Inc. | Frontal sinus spacer |
US8043259B2 (en) | 2004-05-24 | 2011-10-25 | Boston Scientific Scimed, Inc. | Medical device systems |
US20110009895A1 (en) * | 2004-10-27 | 2011-01-13 | Michael Gertner | Methods and Devices to Treat Obesity |
US7879053B2 (en) | 2004-12-20 | 2011-02-01 | Boston Scientific Scimed, Inc. | Balloon with stepped sections and implements |
US20060142784A1 (en) | 2004-12-28 | 2006-06-29 | Stavros Kontos | Device and method for suturing internal structures puncture wounds |
US10064540B2 (en) * | 2005-02-02 | 2018-09-04 | Intuitive Surgical Operations, Inc. | Visualization apparatus for transseptal access |
US8050746B2 (en) * | 2005-02-02 | 2011-11-01 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US7918787B2 (en) * | 2005-02-02 | 2011-04-05 | Voyage Medical, Inc. | Tissue visualization and manipulation systems |
US9510732B2 (en) | 2005-10-25 | 2016-12-06 | Intuitive Surgical Operations, Inc. | Methods and apparatus for efficient purging |
US8906040B2 (en) * | 2005-07-13 | 2014-12-09 | Creighton University | Systems and techniques for minimally invasive gastrointestinal procedures |
US8641729B2 (en) * | 2005-07-13 | 2014-02-04 | Creighton University | Systems and techniques for minimally invasive gastrointestinal procedures |
JP2007097778A (en) * | 2005-10-03 | 2007-04-19 | Ehime Univ | Broken hole reducing apparatus |
US8142470B2 (en) | 2005-12-01 | 2012-03-27 | Atritech, Inc. | Method for accessing the left atrial appendage with a balloon-tipped transeptal sheath |
WO2007106079A2 (en) | 2006-03-10 | 2007-09-20 | The Board Of Trustees Of The Leland Stanford Junior University | Percutaneous access and visualization of the spine |
WO2007147060A2 (en) | 2006-06-14 | 2007-12-21 | Voyage Medical, Inc. | Visualization apparatus and methods for transseptal access |
US20080021546A1 (en) | 2006-07-18 | 2008-01-24 | Tim Patz | System for deploying balloon-expandable heart valves |
US9592369B2 (en) * | 2006-08-21 | 2017-03-14 | Kaneka Corporation | Balloon catheter |
US8900214B2 (en) | 2007-03-30 | 2014-12-02 | Onset Medical Corporation | Expandable trans-septal sheath |
US20090082634A1 (en) | 2007-09-25 | 2009-03-26 | Biten Kishore Kathrani | Surgical method |
US20090143640A1 (en) | 2007-11-26 | 2009-06-04 | Voyage Medical, Inc. | Combination imaging and treatment assemblies |
US20090306685A1 (en) * | 2008-06-10 | 2009-12-10 | Ension, Inc. | Noninvasive trans-catheter method and apparatus for remote suture placement such as for septal defect repair, left atrial appendage closure, pacemaker electrode placement, mitral valve repair, and other inner-cardiac and inner-arterial applications |
US9265918B2 (en) * | 2008-09-03 | 2016-02-23 | Boston Scientific Scimed, Inc. | Multilayer medical balloon |
WO2010028305A2 (en) * | 2008-09-05 | 2010-03-11 | Cardiopolymers, Inc. | Process for generating microwalled encapsulation balloons |
WO2010048427A1 (en) * | 2008-10-22 | 2010-04-29 | Spirx Closure, Llc | Methods and devices for delivering sutures in tissue |
US8460238B2 (en) | 2009-03-25 | 2013-06-11 | Medtronic Vascular, Inc. | Drug delivery catheter with soluble balloon coating containing releasable microspheres and delivery method |
JP5322761B2 (en) | 2009-04-28 | 2013-10-23 | オリンパス株式会社 | Endoscope adapter |
EP2528540A4 (en) | 2010-01-29 | 2013-11-13 | Icon Medical Corp | Biodegradable protrusions on inflatable device |
WO2011143468A2 (en) * | 2010-05-12 | 2011-11-17 | Shifamed, Llc | Low profile electrode assembly |
US8926640B2 (en) * | 2010-07-13 | 2015-01-06 | Lsi Solutions, Inc. | Method and apparatus for closing an opening in thick, moving tissue |
US20120065674A1 (en) * | 2010-08-16 | 2012-03-15 | Levy Michael J | Methods and materials for closing an opening |
US8641757B2 (en) * | 2010-09-10 | 2014-02-04 | Edwards Lifesciences Corporation | Systems for rapidly deploying surgical heart valves |
EP2438933A1 (en) | 2010-09-17 | 2012-04-11 | Eurocor Gmbh | Device for use in treatment of heart valve disease and endocarditis |
US8409224B2 (en) * | 2010-10-04 | 2013-04-02 | Edgar L Shriver | Suturing graft tubes to lumen walls percutaneously |
CN103228317B (en) * | 2010-11-04 | 2016-01-20 | 费城儿童医院 | Magnetic target device, system and method |
US20120259401A1 (en) | 2011-04-08 | 2012-10-11 | Gerrans Lawrence J | Balloon catheter for launching drug delivery device |
EP3560434B1 (en) | 2011-08-18 | 2021-03-03 | Anchor Orthopedics XT Inc. | Suture passer |
US9750565B2 (en) * | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
US9808605B2 (en) | 2011-10-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Controlled porosity devices for tissue treatments, methods of use, and methods of manufacture |
US10485524B2 (en) * | 2011-10-25 | 2019-11-26 | Essential Medical, Inc. | Instrument and methods for surgically closing percutaneous punctures |
WO2013151712A1 (en) * | 2012-04-04 | 2013-10-10 | Gagne Paul J | Methods and systems for ligating a blood vessel |
US8858573B2 (en) * | 2012-04-10 | 2014-10-14 | Abbott Cardiovascular Systems, Inc. | Apparatus and method for suturing body lumens |
US8864778B2 (en) * | 2012-04-10 | 2014-10-21 | Abbott Cardiovascular Systems, Inc. | Apparatus and method for suturing body lumens |
EP4218884A3 (en) | 2012-04-19 | 2023-09-13 | Fractyl Health, Inc. | Tissue expansion devices, systems and methods |
US8827953B2 (en) | 2013-01-15 | 2014-09-09 | Krishna Rocha-Singh | Apparatus and method for delivering intraluminal therapy |
WO2014112101A1 (en) | 2013-01-18 | 2014-07-24 | ソラテック コーポレーション | Heart inner wall checking tool and device for checking heart inner wall |
US20140249563A1 (en) | 2013-03-04 | 2014-09-04 | Covidien Lp | Baloon catheter inflation |
WO2015035354A1 (en) | 2013-09-09 | 2015-03-12 | The Cleveland Clinic Foundation | Endoscope for tissue dissection and visualization |
EP3133975A4 (en) | 2014-04-21 | 2018-01-03 | Clph, Llc | Imaging apparatus and systems and methods for using them |
US20150314110A1 (en) | 2014-05-05 | 2015-11-05 | Hansen Medical, Inc. | Balloon visualization for traversing a vessel |
JP6749558B2 (en) * | 2014-05-14 | 2020-09-02 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Catheter device for transmitting and reflecting light |
JP6816002B2 (en) | 2015-01-23 | 2021-01-20 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Balloon catheter visualization system, method, and device with pledge |
WO2017066495A1 (en) * | 2015-10-13 | 2017-04-20 | Entourage Medical Technologies, Inc. | Surgical closure configurations |
-
2016
- 2016-01-22 JP JP2017538681A patent/JP6816002B2/en active Active
- 2016-01-22 US US15/003,920 patent/US20160213237A1/en not_active Abandoned
- 2016-01-22 EP EP16708482.1A patent/EP3247445B1/en active Active
- 2016-01-22 US US15/003,924 patent/US10285569B2/en active Active
- 2016-01-22 CN CN201680018297.1A patent/CN107529942B/en active Active
- 2016-01-22 WO PCT/US2016/014546 patent/WO2016118875A1/en active Application Filing
- 2016-01-22 EP EP16708759.2A patent/EP3247446B1/en active Active
- 2016-01-22 WO PCT/US2016/014530 patent/WO2016118869A1/en active Application Filing
- 2016-01-22 CA CA2974142A patent/CA2974142C/en active Active
- 2016-01-22 EP EP20191047.8A patent/EP3777952B1/en active Active
- 2016-01-22 JP JP2017538668A patent/JP6548736B2/en active Active
- 2016-01-22 CN CN201680018298.6A patent/CN107529943B/en active Active
- 2016-01-22 EP EP20190762.3A patent/EP3769807B1/en active Active
- 2016-01-22 CA CA2974144A patent/CA2974144A1/en not_active Abandoned
-
2018
- 2018-12-28 US US16/236,274 patent/US10617281B2/en active Active
-
2019
- 2019-06-25 JP JP2019117412A patent/JP6801056B2/en active Active
-
2020
- 2020-03-30 US US16/834,555 patent/US11826020B2/en active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
CN107529942B (en) | 2020-09-22 |
EP3769807A1 (en) | 2021-01-27 |
JP2018502663A (en) | 2018-02-01 |
US20160213237A1 (en) | 2016-07-28 |
US20200221928A1 (en) | 2020-07-16 |
US20160213228A1 (en) | 2016-07-28 |
US11826020B2 (en) | 2023-11-28 |
CA2974142A1 (en) | 2016-07-28 |
WO2016118875A1 (en) | 2016-07-28 |
JP6816002B2 (en) | 2021-01-20 |
EP3247446A1 (en) | 2017-11-29 |
JP2018504213A (en) | 2018-02-15 |
JP6801056B2 (en) | 2020-12-16 |
EP3777952A1 (en) | 2021-02-17 |
EP3777952B1 (en) | 2023-10-11 |
CN107529943B (en) | 2019-11-12 |
JP2019193835A (en) | 2019-11-07 |
EP3769807B1 (en) | 2022-03-02 |
US10617281B2 (en) | 2020-04-14 |
CN107529943A (en) | 2018-01-02 |
US20190174994A1 (en) | 2019-06-13 |
WO2016118869A1 (en) | 2016-07-28 |
CN107529942A (en) | 2018-01-02 |
JP6548736B2 (en) | 2019-07-24 |
CA2974142C (en) | 2021-07-13 |
EP3247446B1 (en) | 2020-08-19 |
US10285569B2 (en) | 2019-05-14 |
CA2974144A1 (en) | 2016-07-28 |
EP3247445A1 (en) | 2017-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10617281B2 (en) | Balloon catheter suturing systems, methods, and devices having pledgets | |
JP6731339B2 (en) | Mitral valve spacer and implantation system and method thereof | |
CN101184454B (en) | Devices, systems, and methods for reshaping a heart valve annulus | |
EP3374017A1 (en) | Direct visualization devices, systems, and methods for transseptal crossing | |
CN108451569A (en) | Medical treatment device for correcting left auricle of heart and relevant system and method | |
US20200383786A1 (en) | System and Method for Reshaping Heart | |
GB2537878A (en) | Method for application of a suture and suturing guides | |
JP5972895B2 (en) | Fixing device | |
CN212346814U (en) | Transcatheter suture implantation device and transcatheter chordae tendineae implantation system | |
CN117224177B (en) | Stitching assembly and stitching system | |
CN219354042U (en) | Plugging device | |
EP4190246A1 (en) | Device for closing a tissue opening | |
CN113017921A (en) | Transcatheter suture implantation device and transcatheter chordae tendineae implantation system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170823 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602016042215 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61M0025100000 Ipc: A61B0001000000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 1/313 20060101ALI20200203BHEP Ipc: A61B 17/064 20060101ALN20200203BHEP Ipc: A61B 17/04 20060101ALI20200203BHEP Ipc: A61B 17/122 20060101ALN20200203BHEP Ipc: A61B 1/018 20060101ALI20200203BHEP Ipc: A61M 25/10 20130101ALI20200203BHEP Ipc: A61B 90/00 20160101ALN20200203BHEP Ipc: A61B 90/30 20160101ALN20200203BHEP Ipc: A61B 17/128 20060101ALN20200203BHEP Ipc: A61B 17/00 20060101ALN20200203BHEP Ipc: A61B 17/068 20060101ALN20200203BHEP Ipc: A61B 17/06 20060101ALN20200203BHEP Ipc: A61B 1/00 20060101AFI20200203BHEP |
|
INTG | Intention to grant announced |
Effective date: 20200226 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016042215 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1302991 Country of ref document: AT Kind code of ref document: T Effective date: 20200915 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201119 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201119 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201221 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201120 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1302991 Country of ref document: AT Kind code of ref document: T Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201219 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016042215 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
26N | No opposition filed |
Effective date: 20210520 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20210122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210122 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210122 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210131 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201219 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20160122 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230523 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20231219 Year of fee payment: 9 Ref country code: IE Payment date: 20231221 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20231219 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |